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Summary 
Schmallenberg virus (SBV) emerged in Europe in 2011. First acute infections were detected 
in cattle in late summer 2011. They induced a short fever period and a marked reduction in 
milk yield in dairy cattle. In a number of farms, especially in the Netherlands, severe 
diarrhoea was a first striking clinical observation. The virus was first identified in November 
2011 and named after the village in Germany where the first definite samples originated from. 
The virus was putatively included in the Simbu serogroup of the genus Bunyavirus family, 
genus Orthobunyavirus. In December 2011, congenital malformation was reported in new-
born lambs in the Netherlands linked to the presence of the virus. Subsequently up to March 
2012, Belgium, Germany, United Kingdom, France, Luxembourg, Italy and Spain reported 
congenital malformations in lambs and calves, and the presence of SBV was confirmed by 
Polymerase Chain Reaction (RT-PCR) testing. 
This was the first time that this virus had been isolated in Europe. Very little information was 
known of this emerging pathogen, most assumptions were extrapolated from scientific 
information available on other viruses of the Simbu serogroup. No efficient diagnostic tools 
were available to assess the actual spread of SBV and its impact on animal health. There were 
no harmonised rules with regard to the control or notification of SBV.  
 
On 23 January the Agriculture Council requested the European Commission to take action 
with respect to the SBV outbreak and in February 2012, the European Commission in close 
collaboration with the Member States identified the priorities and areas for which additional 
information should be gathered prior to consideration of veterinary legislation addressing the 
SBV infections. These were in particular the pathogenesis, the epidemiology, the 
confirmation of the non-zoonotic potential of the virus, and the methods to diagnose the 
disease in animal samples including their validation.  
In March 2012 technical and scientific studies on Schmallenberg virus were started 
commissioned by the European commission and the involved EU member states according to 
Commission Implementing Decision of 27 June 2012. A large part of the scientific studies 
were performed by a five-country consortium (Belgium, Germany, France, United Kingdom 
and The Netherlands) coordinated by the Netherlands. Within this consortium the objectives 
as well as the methods of the studies were discussed repeatedly and in a number of cases 
shifted or adapted based on increased scientific knowledge.   
 
From the SBV technical and scientific studies performed by the consortium coordinated by 
the Netherlands it can be concluded that Schmallenberg virus primarily infects domestic and 
wild ruminants and cattle and sheep seem to be the most susceptible species. Schmallenberg 
virus was introduced in Europe in 2011. After exposure SBV rapidly spread within naive 
herds, and also throughout winter. Blood samples collected before the first clinical cases of 
SBV were observed in Europe in 2011 were all tested negative for SBV antibodies. The origin 
of the virus remains unknown. Certain species of Palearctic Culicoides biting midges are the 
main vectors of SBV. Transovarial SBV-transmission in culicoids has not been observed. In 
pregnant cattle and sheep, the virus can infect multiple organs of the un-borne foetus and this 
infrequently leads to malformations. For detection of SBV sensitive RT-PCR assays have 
been developed and validated and for diagnosis of previous SBV infection reliable virus 
neutralization tests and ELISAs have been developed and validated. Schmallenberg virus was 
detected in semen and embryos from SBV-infected cattle and sheep, respectively. A 
frequency of 0-4% SBV-RNA-positive bovine semen batches was found in the participating 
countries. Subcutaneous injection of SBV-RNA-positive semen in cattle and mice 
demonstrated that semen from SBV-infected cattle may contain viable SBV. In-vitro studies 
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with embryos suggest a negligible risk for SBV-transmission. Whether infectious virus can be 
transmitted to susceptible cows at service or by insemination is unknown.  
As a result of the Schmallenberg virus technical and scientific studies a lot of scientific 
information of Schmallenberg virus issues has been obtained. Increased insights in SBV 
topics and related issues also revealed that there are several important topics remaining for 
which study is recommended. This includes the tracing back of the SBV origin and in relation 
to that the study on SBV strain variation. A risk analysis of possible ways of introduction may 
be helpful to avoid new introductions of SBV-like viruses in future. To better understand the 
role of the arthropod vector in the epidemiology further study of SBV and related Simbu 
serogroup orthobunyaviruses vector competences will be needed. To elucidate the role of 
SBV-contaminated gametes in the epidemiology of SBV studies on SBV transmission via 
artificial insemination are required. To early detect recurrent cases of SBV in ruminants a 
basic surveillance is recommended and to detect new emerging arthropod borne viruses 
monitoring of sentinel herds together with midge trapping may be useful.  
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Area 1 : Pathogenesis 
Main objectives 
To determine replication and virus shedding and to assess the virulence of the virus in young 
and adult animals (in particular in sheep cattle and goat). To determine the dynamics of the 
virus towards and in fetusus and to determine the pathogenicity of the virus in fetuses at 
different gestation stages. To study the development of immunity to Schmallenberg virus. 
This included onset of immunity and estimations of protection of immunity after infection. 
Workplan (concise) 
Infection experiments were done with all three major target species (cattle, sheep and goat). 
Experimental infections in pregnant cattle were carried out by partner D (FLI). Inoculations 
were performed at different gestation stages (around d60, d90, d120 and d150). Inoculation 
route: 1ml subcutaneous titer: 10E5-10E8. FLI prepared a master stock (1ml aliquots x 600-
700) which was used by all partners. The inoculum was bovine serum of 3dpi (assumed to be 
closest to natural infection). 
Experimental infections in sheep were performed by partner NL (CVI) and Be (CODA). 
Inoculations were performed at different gestation stages (around d20, d40 and d60). 
Inoculum: bovine serum 3dpi (assumed to be closest to natural infection). Inoculum was 
provided to partners by FLI. 
 
Experimental infections in goats were performed by partner Fr (ANSES/INRA, LNCR). This 
study involved a large number of animals (>80). Gestation stages at inoculations were 
harmonized with sheep inoculations as much as possible (gestation stages around d20, d40 
and d60).  
 
In the experimental infections, samples for testing immunological parameters were collected 
and provided to partners.  
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1.1 Pathogenesis in pregnant animals  
 
1.1.1 Studies of Schmallenberg virus pathogenesis in pregnant cattle 
 
Following Schmallenberg virus (SBV) infection, ruminants have shown clinical pictures 
which are very similar to AKAV including malformation of lambs, calves and kid goats with 
the arthrogryposis-hydranencephaly-syndrome (AHS) as the guiding symptom complex.  
As for most target species no or only very limited data about duration of viremia, incubation 
time, virus distribution and shedding were available, the collection of experimental data about 
the pathogenesis of Schmallenberg virus for pregnant animals and especially for their fetuses 
was the main target of the study.  
To characterize the dynamics of the virus towards and in fetus, experimental infection studies 
in pregnant cattle at different gestation stages were performed in order to determine the 
pathogenicity of the virus in fetuses at different gestation stages. 
 
 
 
 
In a first animal trial, 4 groups of 6 pregnant heifers each were subcutaneously inoculated 
with the FLI standard SBV challenge virus preparation (2x 0.5ml serum pool, Wernike et al., 
2012) at different stages of pregnancy. All adult animals became infected and showed 
comparable titers and duration of viraemia. In the adult animals no clinical disease was 
recorded, but 3-6 animals of each group showed elevated rectal body temperatures for several 
days. All animals seroconverted for SBV antibodies. 
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A broad panel of maternal and fetal tissue and organ samples as well as body fluids was 
collected at necropsy 6 weeks after infection. 
At post mortem SBV RNA was not detected in the circulation of the dams but in the 
lymphoreticular tissues of each adult animal and in maternal placental tissues of most of the 
animals independently from the stage of gestation at the time point of infection. An overall 
correlation between SBV positive maternal/fetal placenta and positivity of the fetus was 
observed.  
Viral genomes in the fetal circulation were detected in 2 out of 6 fetuses whose mothers were 
infected at d60, in 1/6 at d90, in 3/6 at d120, and in none of the 6 fetuses of the day 150 
group. SBV positive fetal parenchyma were found in all groups with exception of the fetuses 
of the d150 group. 4 fetuses each scored positive in lymphatic tissues in the d60 and d120 
groups and one of the fetuses in the d90 and d150 groups. After infection at the time point 
d120, genome loads were detected in the CNS of 4 animals. 
 
 
 Circulation Parenchyma RES CNS 
Group     d60 2/6 1/6 4/6 2/6 
Group     d90 1/6 1/6 1/6 2/6 
Group   d120 4/6 4/6 4/6 4/6 
Group   d150 0/6 0/6 1/6 0/6 
 
 
Typical malformations with torticollis and arthrogryposis were obvious in only one of the 24 
fetuses. Infection of the corresponding dam was carried out at d90 of gestation. The only fetal 
organ that was found SBV genome positive was the cerebellum of the unborn with a cycle of 
quantification (cq) value of 36. Therefore, no correlation between viral genome loads and 
congenital deformity could be established. 
In conclusion, no common patterns of infected organs could be identified. Sites and amounts 
of virus replication were varying to a high degree in the individual fetuses. Infectious virus 
could not be recovered from the amniotic fluids of the fetuses neither after inoculation on 
insect cells nor in inoculated Vero cell cultures. Moreover, no histological alterations could be 
observed in the fetuses and in situ hybridisation with SBV genome probes was not successful 
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in the progeny. The fetuses were collected at 6 weeks after infection of the dams. Therefore, 
infection was probably already resolved and infectious SBV was eliminated from the fetuses. 
The experimental data confirmed that diaplacental SBV infection in cattle is a very rare event. 
Observations in field studies underline that less than 10% of the offspring of susceptible SBV 
antibody naïve dams are found positive for SBV genomes or precolostral antibodies. In 
summary, it can be stated that the cattle model has turned out to be not really suitable for SBV 
pathogenesis studies due to the very low numbers of malformed calves after in utero infection 
of unprotected fetuses. Case control studies suggest an overall percentage of <1% malformed 
fetuses after SBV infection in cattle. 
As a conclusion of our study, the vulnerable phase of SBV infection in pregnant cattle is 
approximately ranging between day 60 and day 150 of pregnancy. These finding are in 
accordance with field observations after AKAV infection in cattle. Fetuses are refractory to 
SBV infection or replication in the later stages of gestation. This study also confirms a very 
low ratio of precolostral seroconversion in immunocompetent fetuses. After inoculation at 
d150 of gestation none of the 6 fetuses reacted positive for SBV specific antibodies. 
In a subsequent animal experiment, pregnant heifers were infected approximately at d120 of 
pregnancy (d105-120). Inoculum, infectious dose and route of infection were coincident with 
the first trial. In order to elucidate pathogenesis at early stages of SBV infection, necropsy 
was carried out between 10 and 29 days after infection. 2 animals each were sacrificed at 
d10/11, d14/15, and d28/29.  
One of the heifers aborted at day 4 after infection. The fetus could be collected and a nearly 
complete panel of tissue and body fluid samples was acquired.  
One of the heifers was found to be not pregnant at the end of the study. 
The residual 10 pregnant animals yielded normally developed, macroscopically inconspicuous 
fetuses. 
 
 
 
 
Besides raise in body temperatures, no clinical disease was observed in the heifers. 
According to the first experiment, all dams were infected at comparable levels with a duration 
of viremia between 4-6 days. 
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At necropsy SBV genome was detected in lymphoid tissues of all dams. Uterus and maternal 
placenta scored positive up to day 15 post infection (p. i.). 
Fetal parts of the placenta were also tested positive for SBV genome until day 15 p.i.  
Positive RT-PCR results on fetal serum and blood plasma were obtained until day 15 p.i. 
However, only 1 out of 4 fetuses was still positive until d14/15.  
Viral loads in fetal parenchyma were only detected in the aborted fetus (d4 p.i.) and in one 
unborn at d10 p.i. 
After SBV inoculation at d120 of gestation the proportion of infected fetuses was lower than 
in the first experiment: 
 
Study I:  6 / 6 fetuses RT-PCR positive 5 fetuses ≥ 2 organs positive 
 
Study II:  6 / 11 fetuses RT-PCR positive 5 fetuses ≥ 2 organs positive 
 
In the second study a low percentage of infected fetuses was again confirmed.  
Until 4 weeks after infection of the heifers no malformed fetus was detected. 
A low in utero transmission rate of SBV to the fetus was evident, even in early stages of 
infection no relevant genome loads in the developing fetuses were observed. Histological 
investigations are still in progress. 
Abundant virus replication at the maternal/fetal barrage was evident with rapidly decreasing 
numbers of genome copies in fetal/maternal placenta tissues over the time. 
 
 
1.1.2 Transplacental infection in sheep in the first trimester of gestation  
 
In the first year after the recognized introduction of Schmallenberg Virus (SBV) into North-
West Europe musculoskeletal malformations and pathological changes of the central nervous 
system as porencephaly, hydranencephaly and hypoplasia of the cerebellum in new-born 
lambs and calves were the most intriguing clinical features of this infection (1). Therefore, 
SBV joins the group of other teratogenic, arthropod-borne viruses such as Akabane virus. On 
the basis of epidemiological studies of the recent SBV outbreaks and the comparison with the 
pathogenesis of Akabane virus, it is assumed that the teratogenic infection takes place in the 
first trimester; however, the efficiency of transplacental infection generally and in relation to 
the gestation time point is unknown. Also, information on the transplacental transfer and the 
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virus tropism in the uterus and foetus is lacking. Recent studies on central nervous tissue of 
naturally infected, new born lambs and calves have described a differential distribution of 
virus and inflammatory cells, if present in the CNS. In an animal study, the early 
transplacental infection at 5 and 6 weeks of gestation was examined. 
Twenty-one SBV sero-negative ewes (Texelaar breed) of  primo-  or multiparity  were 
acquired from a Dutch herd with a known low incidence of seropositive sheep. The ewes were 
synchronized by hormone treatment and mated by natural mating. This resulted in 95% of 
pregnancy. All pregnant ewes were inoculated subcutaneously with 1 ml of SBV viraemic  
calf serum (provided by, FLI Riems) at either day 38 (n=10, group 1) or day 45 (n=11), group 
2) of gestation.  Ewes were followed for seven days by clinical observation and repeated 
serum analysis was done to demonstrate viraemia by PCR analysis. Seven days post 
inoculation the ewes were euthanized and tissue samples were taken from the reproduction 
tract, especially several placentomes, and from the fetuses (umbilical cord, skull, including  
CNS  and amnion fluid).  All samples were investigated by RT-qPCR for the presence of SBV 
mRNA. 
 
 
 
Figure 4a. Placentome of SBV infected ewe, 7 
days post infection; SBV antigen detected in the 
maternal placental epithelium (close arrow) and in 
the fetal placenta (open arrow), demonstrating the 
transplacental transfer. Note the focal distribution 
of virus antigen and the  lack of inflammation in the 
placental tissue.  Immunohistochemical staining, 
low microscopic power field; M = maternal 
placenta, F = fetal placenta 
Figure 4b. Detection of viral nucleic acid by PCR assay 
in fetuses of ewes (infected at 38 days of gestation) at 7 
days post inoculation. At this time point no virus was 
detected in the blood, but a high virus load was observed 
in the placentomes and dispersion of SBV virus in the 
fetal tissues, including CNS. 
Data show results from two different placentomes, the 
umbilical cord the CNS and amniotic fluid.  
 
Three days after inoculation of the ewes in all, but one ewe sera were positive in the qPCR 
(mean PCR ct value: 21,7 (group 1), 20.9 (group 2)) and during necropsy samples were taken 
from a total of 39 fetuses (n = 20,  group 1) and n = 19, group2).  
No morphological changes were observed at this early time point after infection in any of the 
fetuses. Generally, the placental tissue was unchanged and no inflammatory reaction was seen 
in the placenta. However, by immunohistochemical staining few foci with SBV antigen were 
found in the maternal and fetal placenta epithelium . In these areas also a focal epithelial 
necrosis was observed (Figure 4a). PCR analyses revealed that placentomes taken at seven 
days post infection were positive in all viraemic ewes with a mean ct value of 17.1 in group 1 
and 18.9 in group 2. In all ewes at least one fetus contained SBV nucleic acid  in either 
umbilical cord or CNS. In 85% of the fetuses of group 1 the umbilical cord was positive for 
SBV with a mean PCR ct value of 32.2 and 74% of group 2 with a mean PCR ct value of  
31.7. Skull tissue (including CNS) was SBV positive in 55% of  the fetuses of group 1 and in 
M 
F 
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74% of group 2 with a mean PCR ct value of 33.0 and 34.1, respectively. In 15% (group 1 and 
11% (group2) of the fetal amnion fluids SBV was detected (Figure 4b.).    
From this study it can be concluded, that SBV is able to very efficiently pass the placental 
barrier and infect the fetus in the first trimester of the gestation. The changes in the placenta 
are mild and focal and it is expected that these changes do not directly interfere with the 
functionality of the placenta.   
 
 
1.1.3 Schmallenberg virus experimental infection in pregnant sheep 
 
Methods: 
At CODA-CERVA, 50 SBV seronegative sheep (breed Moureroux) have been synchronized 
and inseminated. After pregnancy was assessed via echography and blood analyses, only 23 
ewes turned out to be pregnant. These were divided in three groups : i) group 1 with 8 ewes 
that were subcutaneously infected with infectious SBV serum (provided by FLI) at day 45 of 
gestation, ii) group 2 with 9 ewes that were infected at day 60 of gestation and iii) control 
group 3 that was mock inoculated (3 at day 45 and 3 at day 60 of gestation) with PBS. Also 4 
non-pregnant ewes were kept in the same experimental unit as an environmental control. 
After SBV inoculation, blood samples and feces were collected each day during the first two 
weeks and afterwards once each week till the end of the experiment. Ewes were kept till the 
end of gestation. When signs of birth became apparent, colostrum was collected, the ewes 
were anesthetized and a caesarian section was performed. Immediately thereafter, ewes were 
euthanized and autopsied and lung, spleen, ovaries, lymph nodes, cotyledons and placenta and 
amniotic fluids were collected. The lambs were assessed for malformations or other aberrant 
clinical signs and their capability to stand up and drink milk was evaluated. Thereafter blood 
was collected followed by euthanasia during which cerebrum, cerebellum, brain stem, spinal 
cord, lymph nodes, spleen, kidney, lung, thymus, muscle tissue, cartilage tissue, reproductive 
organs, umbilical cord and meconium were collected. 
 
Results:  
Analysis by CODA-CERVA of the blood samples collected from the pregnant ewes after 
SBV inoculation at 45 and 60 days of gestation showed that a viremia has occurred in each 
infected ewe. This viremia was followed by a seroconversion in all infected animals and SBV 
has been found at day 4 and 5 pi in the feces of some ewes. No virus or antibodies have been 
detected in the control animals.   
Only one lamb was born before the expected date and was in good health. It drunk colostrum 
from the mother and subsequently showed elevated anti-SBV antibody titers. Few lambs from 
both the control and infected groups were dead at birth but showed no abnormalities. All other 
lambs were born at term, no malformations were observed and they were able to stand up and 
showed a good suction reflex. No anti-SBV antibodies were detected in these lambs.  
When organ tissues from control ewes and their lambs were tested by PCR for the presence of 
the SBV-S segment, all samples were negative. In both the groups infected at 45 and 60 days 
of gestation, maternal tissues like placenta and cotyledons of some ewes were positive. All 
other organs of the ewes were SBV negative. Statistical analysis on the final results will have 
to show if there was a statistical difference between the number of ewes positive for maternal 
tissues in both groups. Of all samples tested from the lambs of the ewes infected at 45 days of 
gestation, only 1 umbilical cord was positive. All other organs were negative. Of all samples 
tested from the lambs of the ewes infected at day 60 of gestation, 3 were positive in the 
umbilical cord, one in brain tissue and another in cartilage tissue.   
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The results show that infection of Mourerous sheep at day 45 and 60 of gestation did not 
induce malformations in the lambs and that only small amounts of SBV RNA could be found 
in some of the lambs at birth. Although a statistical analysis has to be performed, it seems that 
more positive samples were found in lambs originating from ewes that were infected at day 60 
of gestation compared to day 45. Future studies in which ewes are infected at later stages of 
gestation will have to show if malformations can be reproduced under experimental 
conditions. It should furthermore also be pointed that the outcome of infection could be 
influenced by the sheep breed and that till now only one virus isolate, originating from SBV 
infected calves, has been used in these kind of studies. 
 
 
1.1.4 Schmallenberg virus experimental infection in goats 
Field observations and findings from serological survey studies suggest that goats are 
generally less prone to SBV infections and its teratogenic effects in pregnant dams than cattle 
and sheep. However, at present it is still unknown whether this difference is linked to a 
differential susceptibility of the three ruminant livestock species to SBV infections, or is 
rather due to different housing conditions or a preference of Culicoides biting midges for 
cattle and sheep. In two experimental infection studies we have assessed the ability of SBV (i) 
to induce viremia in non-pregnant goats and he-goats, and (ii) to elicit teratogenic effects in  
pregnant goats at two different times of gestation (day 28/42). In a third experimental 
infection study (to be completed in June 2014) we are currently assessing the effects SBV 
infections (prior and concomitant to artificial goat insemination) on the female reproductive 
physiology, fertility parameters, and fetal development. 
 
Methods: 
(Experiment 1 – October/November 2012) A pilot experimental infection study was 
performed at the INRA-PFIE animal experimental platform using 4 non-pregnant goats and 2 
he-goats to test the efficacy of the SBV inoculum (infectious bovine serum pool kindly 
provided by Dr. Martin Beer, FLI; Wernike et al., 2012) to induce viremia in this ruminant 
livestock species. To this end, all animals were inoculated with 2 x 0.5 ml infectious serum 
and monitored during a period of 4 weeks. Whole blood samples were taken daily between 
days 0 and 7 post infection (p.i.) to determine the onset and duration of viremia by qRT-PCR. 
Serum samples were collected weekly to test for SBV-specific seroconversion. Semen 
samples were collected twice weekly from the inoculated he-goats to test for the presence of 
SBV RNA by qRT-PCR. 4 weeks p.i. all animals were euthanized and necropsies were 
performed. Genital tract samples (uterus, oviducts, ovaries, and oocytes) were collected from 
the necropsied goats and subsequently scored for the presence of  SBV by qRT-PCR. 
(Experiment 2 – November 2013 to March 2014) A total of 29 goats were purchased from 
French breeders and tested by the LNCR to confirm their sanitary status (seronegativity for 
SBV, Brucellosis, and Q-Fever). From November 2013, all animals were housed in the insect-
proof experimental facilities at the INRA-PFIE. On December 27
th
 2013 all animals were 
oestrus synchronised using vaginal sponges, and on January 10
th
 2014 an artificial 
insemination (AI) protocol was employed using 2 frozen straws per goat that were obtained 
from one selected he-goat. Pregnancy was assessed by echography and hormonal profile 
analyses on day 21 (24/29 animals positive) and confirmed by echography for 14 out of 29 
goats at day 42 of gestation. The 14 pregnant dams were distributed into 3 different groups: 
groups A (5 animals), B (5 animals), and C (4 animals). The dams of group A were inoculated 
with 2 x 0.5 mL of infectious serum (Wernike et al., 2012) at day 28 of gestation. The dams of 
group B were inoculated with infectious serum at day 42 of gestation. The dams of groups C 
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were mock (PBS)-inoculated at day 28 (2 animals) or 42 (2 animals) of gestation. Whole 
blood samples were taken during 7 days p.i. to determine the onset and duration of viremia in 
the infected dams. During 2 weeks (4 days before infection until 10 days p.i.), the body 
temperature was measured in all dams by using rumen temperature boluses. Serum samples 
were collected weekly during the trial from all dams to test for SBV-specific seroconversion. 
At days 53 to 56 all animals were euthanized and necropsies were performed. The dams and 
foetuses were macroscopically scored for pathological lesions and/or foetal abnormalities and 
a wide array of maternal and foetal tissue samples were collected for downstream analyses 
including qRT-PCR, histopathology, and immunohistochemistry.  
(Experiment 3 – February 2014 to June 2014) A total of 45 goats were purchased and tested 
by the LNCR to confirm their sanitary status (seronegativity for SBV, Brucellosis, and Q-
Fever). Since February 2014, all animals are housed in the insect-proof experimental facilities 
at the INRA-PFIE. The animals will be distributed into 5 different groups: groups A (10 
animals), B (10 animals), C (10 animals), D (10 animals), and E (5 animals). In April 2014 all 
animals will be oestrus synchronised and artificially inseminated as described earlier (see 
Experiment 2). 7 days prior to AI, the animals of group A will be inoculated with 2 x 0.5 mL 
of infectious serum (Wernike et al., 2012). The animals of group B will be inoculated with 
infectious serum on the same day the AI protocol will be performed. Attempts will be made to 
infect the animals of group C by AI with SBV (infectious serum)-spiked semen. At the day of 
the AI, the animals of group D will be inoculated with PBS (mock control). As a control for 
group C, the animals of group E will be artificially inseminated with non-infectious serum-
spiked semen. 
Body temperature measurements and whole blood/serum sample collections will be 
performed exactly as described for Experiment 2. In addition, blood samples will be taken 
from all goats at various time points during the trial to assess by ELISA protocols the putative 
effects of SBV on the endocrinological profile of the infected animals.  At day 35 of gestation 
pregnancy will be assessed by echography, and all non-pregnant animals will be euthanized. 
Tissue samples from the genital tract (uterus, oviducts, ovaries, and oocytes) of the non-
pregnant goats will be collected for downstream analyses including qRT-PCR, 
histopathology, immunohistochemistry, and fertility assays. All pregnant dams will be 
euthanized and necropsied at days 53-56 of gestation. Sampling of maternal and foetal tissues 
and downstream analyses will be performed exactly as described for Experiment 2. 
 
Results: 
(Experiment 1) All goats and he-goats developed viremia without showing clinical signs of 
infection. All genital tract samples from 3 goats (ovaries, follicular fluid, cumulus cells and 
oocytes, uterus) scored negative for the presence of SBV RNA. However, samples of the two 
ovaries (left and right) from 1 goat showed positive qRT-PCR results. For the two he-goats, a 
total of 8 semen batches were collected during the course of the experimental infection. 
However, no SBV RNA was found in all samples processed from fresh sperm or frozen-
thawed semen. 
(Experiment 2) All inoculated dams from groups A and B developed viremia between days 3 
and 5 p.i. and SBV-specific seroconversion from day 14 p.i. In agreement with our 
observations from Experiment 1, no clinical signs of infection (including elevated body 
temperatures) could be observed for the SBV-inoculated animal groups. Upon necropsy, no 
gross lesions could be detected in the maternal carcasses from all groups. All 9 foetuses (1 x 
1, 2 x 2, and 1 x 4 foetuses per dam) obtained from the 4 dams of the control group C showed 
a normal size and morphology. In contrast, among the 11 foetuses (1 x 1, 2 x 2, and 2 x 3 
foetuses per dam) obtained from the 5 dams of group A (SBV-inoculation at day 28 of 
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gestation), we found 3 foetuses from 2 different dams (2/2 and 1/3 foetuses, respectively) 
showing clear abnormalities with respect to size and morphology. A representative gross 
pathological finding is shown in figure 5 (upper panel, foetus 1). In addition, we detected 
slight morphological alterations (haemorrhagic, glossy, and swollen aspect of foetuses) in 2 
foetuses (2/2 foetuses) from an additional dam of group A. Similar alterations were observed 
for 2 foetuses (2/3 foetuses) from 1 of the 5 dams of group B (SBV-inoculation at day 42 of 
gestation). A representative gross pathological finding is shown in figure 5 (middle panel, 
foetuses 1 and 2). All the other of the 10 foetuses (1 x 1, 3 x 2, and 1 x 3 foetuses per dam) 
obtained from the 5 dams of group B showed a normal size and morphology. Further analyses 
described in the study design are being performed at the present time and will complement 
our macroscopic findings. 
 
Figure 5. Gross pathological findings representative for some of the foetuses obtained from dams of groups A 
(SBV-inoculation at day 28 of gestation) and B (SBV-inoculation at day 42 of gestation). Normally developed 
foetuses from group C (mock control) are shown for comparison. Note the different size and morphology of 
foetus 1 from animal #046 (group A) compared to normally developed foetuses 2 and 3 from the same dam. 
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1.2 Pathogenesis in non-pregnant animals 
 
 
1.2.1 Pathogenesis of different SBV isolates in cattle 
 
To study differences in the pathogenesis caused by different SBV isolates, three 6-months-old 
Holstein cattle were infected with any of three whole-blood or serum samples obtained from 
cattle in the field in 2012 or from cattle experimentally infected with a SBV isolate from 
2011. The table below (Table 2) gives the origin, Cq values, the preparation of the inocula and 
the infected animals. All specimens were stored at 4°C until experimental infection. The three 
cattle were subcutaneously infected at multiple sites in the shoulder and dorsal thorax regions.  
 
 
Table 2.  Animals, origin and preparation of inocula used for SBV infection of cattle. 
 
Cattle (C) 
no. 
Submission/ 
Identification no. 
Origin (federal state) Inoculum Cq-value 
C2 648/12-1 Hessen 2 ml whole blood
a
 + PBS 20 
C3 
612/12-3 
+ 612/12-4 
Baden-Wuerttemberg 
2 ml whole blood
a 
+ 2 ml whole blood
a
 
26 
+ 22 
C4 
Challenge-Serum 1 
(Cattle no. 20)
b
 
North Rhine-
Westphalia 
2 ml serum 26 
a
 containing potassium EDTA and antibiotics; 
b
 obtained from cattle experimentally infected with SBV; PBS, 
phosphate buffered saline 
 
Serum and whole-blood samples were collected 2, 3, 4, 5, 6, 7, 10, 12, 14, 17, 21 and 28 days 
post infection (dpi). The samples were analysed for SBV-RNA and antibodies using real-time 
RT-PCR (RT-qPCR) and ELISA, respectively. At post-mortem examination at 31 dpi, tissue 
samples were collected from spleen, liver, lung and from mediastinal, mesenteric and 
mandibular lymph nodes. Rectal temperature and clinical signs were monitored daily for the 
duration of the experiment.  
 
SBV-RNA was detected earlier (from 2 to 6 dpi) in C2 and C3 than in C4 (from 3 to 10 dpi). 
Cq values were similar for serum and whole blood (data of whole blood samples not shown) 
(Fig. 6). Seroconversion was detected 12 dpi or 14 dpi. Rectal temperature and clinical signs 
were not observed in any of the cattle. At post-mortem examination, SBV-RNA was found in 
the spleens and mesenteric lymph nodes of all cattle, in mesenterial and mandibular 
lymphnodes of two cattle, but not in the livers or lungs (Table 3).  
 
The late onset of the infection in C4 was possibly due to long storage of the challenge serum 
at 4°C: 6 months compared to approximately 2 to 5 weeks of storage of the whole blood 
samples. However, no other differences in the pathogenesis of SBV infection were found 
between the SBV isolates.  
 
Table 3. Cq-values of tissue samples collected at post-mortem examination 31 dpi. 
 
Cattle (C) 
no. 
SBV-S3 RT-qPCR 
Spleen Liver Lung Mediastinal lnn. Mesenteric lnn. Mandibular lnn. 
C1 29.74 No Cq No Cq 37.53 35.60 No Cq 
C2 34.29 No Cq No Cq 35.21 32.77 32.83 
C3 31.78 No Cq No Cq No Cq 26.85 33.45 
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lnn., lymphnodes 
 
 
Figure 6. Progression of the amount of SBV-RNA and antibodies in serum of cattle comparatively infected with 
any one of three different SBV isolates. The ELISA cut-off was set according to the current manufacturers’ 
recommendation. 
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1.2.2 Pathogenesis of a German SBV containing serum collected from cattle in 2012 in 
experimentally infected sheep 
 
In the previous section, we reported the experimental infection of 6-month old Holstein calves 
with SBV isolates from cattle originating from different federal states in Germany. Cattle (C) 
no. 3 (‘TV13/12_R790’) was subcutaneously injected with 2 ml of antibiotic treated whole-
blood collected from two cattle from Ravensburg (Cq 26) respectively Biberach (Cq 22) in 
Baden-Wuerttemberg, Germany, in August 2012. Serum collected from this calve at 4 dpi (Cq 
22.75) was injected in sheep to investigate whether the serum contains infectious SBV 
suitable for SBV challenge infection of sheep (and cattle). 
 
Methods: 
Five lambs were purchased from local German breeders. After acclimatisation of the animals, 
serum was collected one week before experimental SBV infection, to proof them free of 
circulating SBV-RNA and antibodies. Each of the five sheep was inoculated twice with 0.5 
ml of the serum of C3 at two locations in the shoulder region. Serum samples were collected 
for serological and virological analyses daily from 1 to 10 dpi and at, 14, 21, 28 and 29 dpi. 
Spleens and mesenteric lymph nodes were collected post-mortem at 29 dpi.  
Serum samples were tested for SBV RNA and antibodies by ELISA and SBV-S3-specific RT-
qPCR (Bilk et al., 2012). 
 
Results: 
All five sheep seroconverted between 6 and 10 dpi and remained seropositive until the end of 
the study at 29 dpi. SBV-RNA was detected in serum at 1 or 2 dpi for a period of 3 to 4 days 
and in spleen and/or mesenteric lymph nodes of 4 of 5 sheep (Table 4) at 29 dpi. One sheep 
(S30) was negative for SBV-RNA in the tested tissue samples although the serological and 
virological results were similar to those of the other sheep.  
 
 
Table 4. Cq-values of tissue samples collected post-mortem at 29 dpi. 
 
Sheep (S) no. SBV-S3 RT-qPCR 
Spleen Mesenteric 
lymph nodes 
S7 38.4 No Cq 
S17 No Cq 34.8 
S24 33.3 No Cq 
S27 32.1 37.2 
S30 No Cq No Cq 
 
 
Serological and virological results were similar to those of sheep and cattle experimentally 
infected with other SBV sera in previous studies. Presence of SBV-RNA in spleen and 
mesenteric lymph nodes is a common finding in most, but not all, SBV-infected ruminants 
(Wernike et al., 2013). The SBV serum collected from and passaged in cattle has proven to be 
infectious for sheep and can therefore be used for challenge infections in the future.  
 
Other laboratories (including AHVLA and CVI)  also isolated a SBV strain from cattle and 
carried out an initial characterisation in a sheep model, which confirms that biologically 
characterised isolates can be used alike. 
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1.2.3. Influence of inoculation route and inoculation dose on SBV infection in sheep 
 
Methods: 
At CODA-CERVA, two experimental infection experiments in sheep (Mourerous) have been 
performed to address the i) impact of the inoculum route and ii) the impact of the inoculum 
dose on the outcome of infection. In the first experiment, three groups of three ewes each 
were infected with an SBV infectious serum (provided by FLI) via either the intranasal, 
intradermal or subcutaneous route. In the second experiment, four groups of three ewes each 
were subcutaneously infected with either an undiluted or 1/10, 1/100 or 1/1000 dilution of the 
SBV infectious serum provided by FLI. In each experiment, blood samples were collected 
daily and animals were euthanized at 10dpi. At autopsy, samples from brain, lymph nodes, 
spleen and lung were collected. 
 
Results: 
In any of the two experiments, sheep showed clinical signs upon SBV infection. The results 
showed that both intra-dermal and subcutaneous infections could induce productive SBV 
infections based on the presence of an RNAemia and seroconversion by the end of the 
experiment. The intranasal route of infection did not result in a productive infection but virus 
could however be detected in the feces. The experiment with the different inoculation doses 
showed that a critical amount of virus has to be administered to induce a productive infection 
since all animals inoculated with the undiluted and 1/10 diluted serum became RNAemic 
while only 1 sheep inoculated with the 1/100 dose and none of the sheep inoculated with the 
1/1000 dose became RNAemic. Interestingly, when a sufficient amount was administered to 
induce a productive infection, no statistical difference in the length and height of RNAemia 
was found between the different inoculum doses. All animals that became RNAemic 
seroconverted before the end of the experiment. Anti-SBV antibodies could however only be 
detected by seroneutralisation tests and not with a commercial ELISA, probably because the 
latter only detected IgG antibodies that are most probably not yet present at those early time 
points post infection. 
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1.3  Pathogenesis in seropositive and seronegative animals 
 
Results from in vivo studies and from the field indicate the persistence of SBV in cattle and 
sheep. However, some animals have declining antibody titres arguing against a persistent 
infection in all animals.  
 
 
Methods: 
Partner AHVLA infected a group of 12 sheep with the infectious serum provided by FLI in 
February 2012 and maintained these sheep for one year. At the end of this period, we killed 
some to test for the detection of SBV persistence. The investigations into this aspect are 
ongoing. In addition, an immunosuppressive drug (dexamethasone) was appllied  in four 
animals seeking for a reactivation of virus. The final group of 4 animals was re-challenged 
one year after infection. At that time, these animals had still detectable Ab titres, but in most 
cases well below their immediate post infection levels.  
A commercially available vaccine was bought at the end of September 2013 and 12 sheep 
were vaccinated as per manufacturer’s instruction at the beginning of October 2013. One 
group of these sheep was challenged at the end of February 2014 another one at the end of 
March 2014.  
 
Results: 
The analysis in this topic is not concluded yet, but indicates the following conclusions: We 
detect (as described by others alike) SBV in some kind of persistent form in mesenteric Lnn 
and spleen. The precise location therein remains subject of further analysis.  
Unfortunately we could not obtain industry support to obtain vaccine products before 
marketing making it impossible to analyse the duration of immunity conferred. Our results 
indicate so far that animals mounting an antibody response are protected up to 4 months after 
vaccination (analysis will be continued after the end of the project).  
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Area 2. Epidemiology 
Main objectives 
To clarify or exclude horizontal transmission. To investigate which arthropod species may be 
potential vectors for Schmallenberg virus. To clarify if there is a potential risk of transmission 
of Schmallenberg virus via semen and embryos. To investigate if SBV is excreted in semen or 
may be transmitted via embryo’s. To determine if pigs (and several other species) can play a 
role in the epidemiology of SBV and represent a trade issue. To obtain an estimate of possible 
SBV infections in wildlife species.  
Workplan (concise) 
To elucidate if horizontal transmission of SBV is possible antibody responses in non-
inoculated controls were monitored. Inquiries were made on how to assess potential intranasal 
and contact infections (partner UK, AHVLA).  
Retrospective vector studies were done in all five countries of the consortium and by all 
partners. Retrospective and prospective vector studies were done in The Netherlands, France 
and Germany.  
 
To investigate the role of semen a large number of batches were tested. The test protocol of 
choice was the SBV S-segm RT-PCR and processing of samples was essentially according to 
Vanbinst et al. (J Virol. Meth. 169: 162-168). 
To investigate the role of embryo’s an experimental infection study in in vitro produced 
embryos was performed in France (UNCEIA). Virus, embryos and semen for this study were 
provided by partner institutes in France. 
 
SBV specific antibodies were determined by different partners in several wildlife species and 
also in horses swine, camelids and mice. An experimental infection study in pigs was 
performed in Belgium. Infection experiments in other species were performed by different 
partners: poultry, llamas, alpacas and IFNAR mice (FLI), rabbits, hamsters, IFNAR mice 
(ANSES, CVI) 
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2.0.1 Transmission of Schmallenberg virus during winter, Germany 
 
Methods: 
The emergence of SBV-infection in sheep was monitored on a farm with 1000 ewes in 
Mecklenburg-Western Pomerania, Germany in winter 2012/2013. Blood samples were taken 
from 60 sheep in September 2012 and from additional 15 and 90 sheep on January 10 and in 
January through February, respectively (Fig. 5). The samples were tested for SBV-RNA and 
antibodies by SBV-specific real-time RT-PCR and indirect ELISA, respectively.  
 
Results: 
Serum samples collected in September and on January 10 from the 75 sheep were all negative 
for SBV antibodies. However, samples from 4 of 15 sheep that were tested in January 
revealed PCR-positive results (Cq-values 31.6 to 39.9). Blood from 1 of the 4 sheep was 
found infectious for two inoculated interferon alpha/beta receptor deficient (IFNAR) mice. Of 
the 90 additional sheep, 9 were SBV seropositive in January and two showed doubtful ELISA 
results. Four weeks later, 1 of the 2 latter sheep was tested SBV seropositive, and 1 and 2 
sheep, which were previously found seronegative, showed doubtful and positive ELISA 
results, respectively (Fig. 7).  
During the study period, PCR-confirmed SBV cases were also recorded for 52 adult cattle and 
sheep by the German Animal Disease Reporting System (TSN) in other German federal states 
of Germany between the 1st of January and 20th of February 2013 (Fig. 8).  
This study indicates that SBV transmission occurred in early January at a low level. In the end 
of February 2013, 13% of the 90 sheep were seropositive, which contrasts within-herd 
seroprevalence of >90% found in other ruminant herds in 2011 (Loeffen et al., 2012; Wernike 
et al., 2013c; 2013d). During the sampling period in 2013, a temperatures increase to 5 or 6°C 
for several consecutive days with a maximum of 9°C was measured (Fig. 9), and vector 
activity was confirmed by a single Culicoides biting midge that was caught in a UV-light trap 
in the end of January on the study farm.  
 
In conclusion, transmission of SBV by hematophagous insects seems possible, even during 
the winter in central Europe, if minimum temperatures rise above a certain threshold for 
several consecutive days (Wernike et al., 2013c). 
 
 
Figure7. Serological results as measured by SBV ELISA. The cut-off values of the ELISA are marked by a 
dashed line. Blood samples were taken twice four weeks apart. The results of the first sampling are depicted in 
grey or dark red (S31, S38, and S58, negative or doubtful at this time), of the second one in black or red (S31, 
S38, and S58, positive at the second sampling).  
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Figure 8. PCR-confirmed SBV cases in adult cattle (black bars) or sheep (grey bars) recorded by the German 
Animal Disease Reporting System (TSN) between the 1st of January and 20th of February 2013 (Wernike et al., 
2013c). 
 
 
 
 
 
Figure 9. Climate versus sampling data. The maximum temperatures are shown in red and the minimum 
temperatures in blue. Snow cover is symbolised by a grey area. The dashed line represents the day of the 
detection of SBV genome in four sheep. Further sampling days are marked by dotted lines (Wernike et al., 
2013c).  
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2.0.2 Dynamics of Schmallenberg virus infection within a cattle herd in Germany, 2011 
 
Methods: 
A cattle herd located approximately 9 km from the initial holding near the city of 
Schmallenberg (Hoffmann et al., 2012) was closely monitored between May 2011 and 
January 2012 in the context of a tick-borne fever surveillance (Nieder et al., 2012; Wernike et 
al., 2013d). During the study six cattle were slaughtered or culled, which were all unrelated to 
SBV-infection, and no animals were introduced from outside. Milk yield and body 
temperature were monitored in regular intervals. The detection of an increase in body 
temperature in an animal was followed weekly and, later, bi-weekly blood sampling intervals. 
Blood samples were taken at several dates (n=58, Fig. 10) from all dairy cows of the farm and 
analysed for SBV antibodies by a SBV competition ELISA. Samples taken between August 
and October 2011 were tested by S-segment-specific real-time RT-PCR (Bilk et al., 2012).  
 
Results: 
Every sample taken between calendar weeks 18 and 37 tested seronegative by ELISA. PCR-
positive results and seroconversion were first detected in calendar weeks 37-40, and from 
week 41 SBV antibodies were detectable in all tested serum samples (Figs. 10 and 11). 
A decrease in milk yield and an increase in body temperature, stillbirth or malformed 
offspring were reported after SBV-infection of cattle by other groups. In the present study, a 
decrease of the milk yield after SBV-infection was not observed. The onset of fever was 
rarely (n=3) associated with SBV-infection and suggests that SBV-infection of all other 
animals occurred without initial fever. Premature, stillbirth or malformed offspring were not 
observed, although 12 of the tested pregnant cows were infected with SBV in September 2011 
during the period of pregnancy (days 75 to 175 after conception) that is critical for the cause 
of stillbirth or birth of malformed calves.  
In the present study, RNAemia was only detected on a single day in a few cattle (n=6) and not 
detectable in all other animals, despite continuous sampling. A short viraemia of a few days 
was also observed after experimental inoculation of cattle with SBV. Seroconversion varied 
from 4 days to 2 weeks after a PCR-positive result, which is similar to seroconversion 
recorded in cattle experimentally infected with SBV (8 days to 3 weeks after infection). 
In this study, a rapid spread of SBV infection throughout the entire herd (100%) was 
observed, which confirmed the high within-herd seroprevalence in cattle and sheep herds 
from affected areas that was reported by other groups. The entire study herd was infected with 
SBV between September and mid-October – during the main Culicoides-vector season in 
Northern Europe.  
 
After SBV  emergence during the first vector season, SBV has obviously spread rapidly and 
efficiently within naïve herds exposed to SBV. The study results confirm the previous 
evidence for the first entry of SBV in Europe at the end of the summer in 2011 and allows 
further insights into SBV epidemiology (Wernike et al., 2013). 
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Figure 10. ELISA and real-time RT–PCR results of all dairy cows kept on the monitored farm between calendar 
week 18 of 2011 and week 8 of 2012. Serum samples tested negative by ELISA are depicted in green, doubtful 
in yellow, and positive in red. PCR-positive samples are framed in black, body temperatures exceeding 39.5 °C 
are indicated by ‘f ’, and the numbers of primiparous animals are depicted in blue. 
 
 
Figure 11. Percentage of samples positive by ELISA during  the course of 2011. Doubtful results were 
considered as seropositive.  
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2.0.3 Collection of SBV case data in Germany 
 
Case data have been retrieved from the German national animal disease database (Zentrale 
Tierseuchendatenbank) in the Animal Disease Notification System (Tierseuchennachrichten, 
TSN) to report these data to EFSA for supranational reporting a joint risk assessment. 
Routines have been created for the fast convenient extraction of the required data from the 
database and the need for manual handling of the data minimized. The data were reported to 
EFSA within the foreseen deadlines. Moreover, data on the re-occurrence of SBV in Germany 
during the vector-active season in 2012 were analysed, compared to the previous year and the 
results published (Conraths et al., 2013). 
The database has also been evaluated to assess the impact of SBV on cattle, sheep and goat 
holdings at the level of the German federal states (Table 5).  While the proportion of cattle 
holdings with reported SBV cases is generally low (1.02 % on average; 0.00-2.73 min.-max.), 
it is much higher in sheep and widely varies between regions in sheep (4.36 % on average; 
0.00-23.08). In North Rhine-Westphalia, i.e. in the centre of the epidemic, the proportion of 
sheep holdings with reported SBV-cases was as high as 12.01 %. 
 
 
Table 5. SBV-affected cattle sheep and goat holdings 
 
Cattle farms SBV in cattle % Sheep farms SBV in sheep % Goat holdings SBV in goats %
Germany  144 850 1473 1,02  22 273 971 4,36  11 219 50 0,45
Baden-Württemberg                                 17 991 70 0,39  2 921 39 1,34  2 574 7 0,27
Bavaria  54 731 461 0,84  6 255 49 0,78  3 819 1 0,03
Berlin                                              10 0 0,00   8 1 12,50   8 0 0,00
Brandenburg                                        2 572 26 1,01   630 24 3,81   263 0 0,00
Bremen                                              95 0 0,00   10 0 0,00   9 0 0,00
Hamburg                                             110 3 2,73   26 6 23,08   11 0 0,00
Hesse  8 623 125 1,45  1 553 141 9,08   761 9 1,18
Mecklenburg-W. Pommerania                            2 067 17 0,82   529 14 2,65   136 1 0,74
Lower Saxony  21 093 235 1,11  2 480 147 5,93   884 6 0,68
North Rhine-Westphalia  16 610 294 1,77  2 299 276 12,01   881 14 1,59
Rhineland-Palatinate  5 314 54 1,02   966 40 4,14   424 5 1,18
Saarland                                            686 1 0,15   148 4 2,70   63 2 3,17
Saxony  3 532 18 0,51  1 275 44 3,45   367 0 0,00
Saxony-Anhalt  1 598 19 1,19   424 23 5,42   144 2 1,39
Schleswig-Holstein                                 7 943 115 1,45  1 925 110 5,71   537 1 0,19
Thuringia  1 875 35 1,87   824 53 6,43   338 2 0,59
SBV Data as of 14.01.2014; Farms: Destatis Viehhaltung der Betriebe Agrarstrukturerhebung - Fachserie 3 Reihe 2.1.3 - 2010  
 
 
2.0.4 Case/Control study in cattle, sheep and goats, Germany 
 
A case/control study has been designed and implemented for cattle and sheep together with 
veterinary authorities in several German states and the University of Veterinary Medicine in 
Hanover. With regards to goats, it has been decided that a case/control study in this species 
(90 holdings) is conducted by the University of Veterinary Medicine in Hanover, Clinic for 
Small Ruminants, and that the FLI will assist in the evaluation of the data. 
For cattle and sheep, it was planned to include at least 30 case and 30 matching control farms 
per species. Cases were farms with at least one confirmed case of SBV-infection (PCR or 
virus isolation) along with clinical indication of SBV infections in the holding (birth of 
malformed offspring with AHS, PCR-confirmed acute infection in adult dams). Controls were 
holdings without indication of clinical SBV-associated disease. To verify the status control 
holdings, at least 14 animals per farm were serologically tested (by IFAT or ELISA) to detect 
a seroprevalence of 20% at the 95% confidence level. All serum samples were collected, sent 
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to the Institute for Epidemiology of the FLI, registered and passed to the Institute for of 
Diagnostic Virology of FLI for testing, and the results recorded in a database. 
It was originally planned to conduct the study in North Rhine-Westphalia and Lower Saxony, 
but due to the rapid spread of the disease and the interest of other federal states to contribute 
to the study, it was decided to include also holdings in Schleswig-Holstein, Rhineland –
Palatinate, Hesse, Saxony-Anhalt and Brandenburg. This led also to an adaptation of the 
planned numbers of case and control holdings. 
 
All farms were visited by veterinarians who sampled the animals as described above and 
conducted structured interviews with a standard questionnaire. The standard questionnaire, 
made available as an excel spread sheet that allows automated upload of data into a database, 
was jointly developed with members of the veterinary services of the federal states 
participating in the study and with the Clinic for Small Ruminants of the University of 
Veterinary Medicine in Hanover.  
The questionnaire was used to record details on the visited holdings and vets serving it, 
species of animals kept, number of animals per species, production type, husbandry and farm 
management practices, hygienic status, treatments; diseases, cleansing and disinfection 
management, observed clinical symptoms in case herds, fertility, farm contacts, observations 
on vector abundance, use of repellents and insecticides, potential wildlife disturbances etc. 
The questionnaire was made available to other partners in the Schmallenberg Response Group 
jointly convened with EFSA. Interviewers were trained before they did the interviews. 
A database was designed and programmed to take up the interview data and the results of 
diagnostic testing (IT personnel employed through the project). A PhD student was employed 
for data management and evaluation (employed through the project). 
Data were obtained for a total of 108 holdings (50 cattle and 58 sheep holdings; 29 case 
flocks, 29 control flocks). Herds and flocks with confirmed cases of SBV-infections in 
malformed fetuses were regarded as case holdings (cattle: 33 case holdings; sheep: 29 case 
holdings). Herds and flocks without such cases were preliminarily attributed to the control 
group (cattle: 17 case holdings, 29 control holdings). On each holding, at least 14 animals 
were blood-sampled and tested for antibodies to SBV by ELISA. Control holdings, in which 
the number of seropositive animals did not exceed 4 or 28.6%, remained in the control group. 
Holdings with a higher seroprevalence (10 cattle herds and 13 sheep flocks) were excluded 
from the study leading to a final study population of 33 cattle case plus 7 cattle control 
holdings and 29 sheep case and 16 sheep control holdings. 
It should be noted that control holdings could mainly be found in the peripheral areas of the 
SBV-affected region, i.e. in Brandenburg, Rhineland-Palatinate and Schleswig-Holstein (Fig. 
12). The study design, emerging problems (difficulties to identify control holdings due to the 
fast and efficient spread of the infection in the study area) and preliminary results were 
discussed within the EFSA Schmallenberg Response Group to prepare for joint meta-analysis.  
 
Statistical analysis of the collected data (bivariate and multivariate testing) was conducted to 
identify potential risk factors using the statistical software “R” (http://www.r-project.org/; 
version 4.0) and an optimised logistic regression model produced. Selection of the variables 
included in the optimised model was based on the p value, the Akaike Information Criterion 
(AIC) and pseudo R
2 
values. In a first step, those variables were considered for inclusion in 
the model that had a p- value < 0.1 in bivariate testing or explained more than 10% of the 
outcome variable (pseudo R
2 
> 0.1). The AIC value was then used as an additional indicator 
of the model quality to rank the explanatory variables with regard to their impact. 
 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
27  
 
 
 
Figure 12. Spatial distribution of case and control holdings. 
 
Results: 
Bivariate analysis 
 
Cattle 
Bivariate testing indicated statistically significant associations with an Odds Ratio (OR) >1, 
i.e. potential risk factors) between the following variables and the outcome variable: 
 
 Occurrence of malformations (OR 93.0) 
 Animals kept temporarily indoors (OR 32.5) 
 Bull kept for a natural mating (OR inf) 
 Purchase of animals during the study period (OR 7.2) 
 
The variable “Occurrence of malformations” must be regarded as a clinical expression of the 
response variable (occurrence of SBV infections, i.e. case holding) and was therefore 
excluded from further analysis. 
Bivariate testing indicated statistically significant associations with an Odds Ratio (OR) < 1, 
i.e. potential protecting factors) between the following variables and the outcome variable: 
 
 Animals kept indoors permanently (OR 0.03) 
 Use of a milking robot recording individual performance (0.13) 
 Presence of other factors with a negative impact on reproduction (0.00) 
 Presence of migrant sheep flocks in the area (OR 0.11) 
 
”Region” (i.e. the location of the farms relative to the centre of the epidemic) emerged as a 
potential risk factor for clinically apparent SBV infection due to the heterogeneous spatial 
distribution of SBV infections in the study region in Germany. 
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Sheep 
Bivariate testing indicated statistically significant associations with an Odds Ratio (OR) >1, 
i.e. potential risk factors) between the following variables and the outcome variable: 
 
 Abortions observed (OR 22.0) 
 Stillbirth (OR inf) 
 Occurrence of malformations (OR 202.5) 
 Flock regularly visited by a vet (OR 5.8) 
 Animal holder assists at the birth and observed increase in abortions and 
malformations (OR 27.1) 
 Abortions/malformations observed in animals new in the flock (OR inf) 
 Abortions/malformations observed in older sheep (OR 103.5) 
 Abortions/malformations observed in lambs with mobility disorders (OR inf) 
 Increased number abortions/malformations as compared to previous periods (OR inf) 
 Reproduction disorders in ewes (OR 15.2) 
 
Most of these variables represent expressions of the same phenomenon and must be regarded 
as a clinical expression of the response variable (occurrence of SBV infections, i.e. case 
holding). The following variables were therefore excluded from further analysis: abortions 
observed; stillbirth, occurrence of malformations, animal holder assists at the birth and 
observed increase in abortions and malformations, Abortions/malformations observed in older 
sheep, abortions/malformations observed in lambs with mobility disorders, increased number 
abortions/malformations as compared to previous periods. 
Bivariate testing indicated statistically significant associations with an Odds Ratio (OR) < 1, 
i.e. potential protecting factors) between the following variables and the outcome variable: 
 
 Poultry kept (OR 0.1) 
 Mating all year (OR 0.0) 
 Keeping hair sheep (0.11) 
 
 
Multivariate analysis 
 
Cattle 
A total of 13 variables with a p value < 0.1 or explaining more than 10% of the variance of 
the outcome variable were included in the full logistic regression model. 
The model with the best pseudo R
2 value (0.595) included the variables “animals kept indoors 
permanently” (protecting factor), “purchase of animals during the study period” (risk factor), 
“presence of migrant sheep flocks in the area” (risk factor). ROC analysis revealed that this 
model discriminates reliably between case and control holdings (AUC 0.92). 
 
Sheep 
A total of 8 variables with a p value < 0.1 or explaining more than 10% of the variance of the 
outcome variable were included in the full logistic regression model. 
The model with the best pseudo R
2 
value (0.483) included the variables “poultry kept” 
(protecting factor) and “reproduction disorders in ewes” (risk factor). ROC analysis revealed 
that this model discriminates reliably between case and control holdings (AUC 0.86). In 
another model, the variables “poultry kept” and “flock regularly visited by a vet” (risk factor) 
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were combined and yielded a pseudo R
2 
value of 0.473 and an AUC of 0.86 in ROC analysis. 
A third model included the potential risk factors “reproduction disorders in ewes” and “flock 
regularly visited by a vet” and had a slightly lower pseudo R2 value of 0.390 and an AUC of 
0.80 in ROC analysis. The presence of the variable “flock regularly visited by a vet” indicates 
that monitoring the health status of a flock helped to identify SBV infections. We have 
currently no plausible biological explanation for the finding that the presence of poultry in a 
sheep holding represented a statistically significant protective factor by both, bivariate testing 
and multiple logistic regression analysis. 
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2.1 Transmission pathways 
 
2.1.1 Horizontal transmission  
 
 
2.1.1.1 Intranasal inoculation in sheep 
 
Methods: 
At the AHVLA, experimental infections in sheep were performed to assess the ability of virus 
to cause clinical disease in lambs following intranasal inoculation. At first a group of 6 
animals received approximately 10
4
 TCID50 in 1 ml of UK isolate from a brain sample.  
A further group of sheep (n=7) were inoculated intranasally using a well-defined isolate that 
could be grown to a high titre. While this high titre of inoculation might not represent the 
situation in the field, it should be noted that SBV is widely present on infected offspring 
during birth.  
 
Results: 
All sheep inoculated, irrespective of route, failed to develop clinical disease and all remained 
serologically negative. SBV could not be detected by RT-qPCR in any of the sheep (blood) 
post intranasal infection. 
 
 
2.1.1.2 Antibody responses in susceptible controls 
 
In none of the experimental infection studies, antibody responses in non-inoculated controls 
which were kept in contact with inoculated animals, were observed, neither in cattle, nor in 
sheep or goat. There never have been indications for direct horizontal transmission of SBV. 
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2.2  Transmission-competent vectors 
     
2.2.1 Retrospective studies 
 
Methods: 
Netherlands retrospective study 2011 
Culicoides were trapped almost daily throughout September and early October, 2011 at a 
dairy herd and at two locations in the vicinity of sheep (Elbers et al., 2013). Prior to assay, 
working under a dissecting microscope and using a scalpel, the head of each midge was 
separated away from the rest of the abdomen; 10 heads per species were then pooled and 
assayed for Schmallenberg virus (SBV), whereas the corresponding abdomens (also pooled) 
were stored away in 70% ethanol. A total of 610 pools (10 heads per pool) were assayed. 
Only when a pool of 10 heads was found SBV-positive was the corresponding pool of 
dissected abdomens retrieved and assayed individually. 
 
Germany retrospective study 2011 
Biting midges were trapped by OVI (Onderstepoort Veterinary Institute) traps, BG-Sentinel 
biting midge traps, BG Sentinels and EVS traps at 28 sites in Western Germany within other 
projects than the SBV project and made available for testing. All midges were pooled in 
groups of 1-50 individuals, according to species, collection date and site, for Schmallenberg 
virus (SBV) screening. Additionally, 48 pools containing 673 black flies (Simuliidae), caught 
in 2011, were screened for the virus without being identified to species prior to testing. 
By the end of 2013, realtime RT-PCR (Hoffmann et al. 2012) screening for SBV was 
conducted on 4,999 biting midges and 633 black flies collected between April and October 
2011.  
 
Belgium retrospective study 2011 
Culicoides collected at 16 locations (divided over 4 regions) in Belgium with OVI 
(Onderstepoort Veterinary Institute) traps between July and November 2011 were 
morphologically identified and physiologically examined. Species specific pools originating 
from parous females containing maximum 25 heads were prepared. The RNA from these 
pools was extracted using the MagMAX Total Nucleic Acid isolation kit and the MagMAX 
Express-24 purification system. Obtained RNA was thereafter subjected to a qRT-PCR 
detecting the SBV-S segment. In total, 7305 midges divided over 480 pools were screened for 
the presence of SBV (De Regge et al., 2012). 
 
Results:  
Retrospective studies 2011, Netherlands 
SBV was detected in several different Culicoides species (Elbers et al., 2013): C. obsoletus 
sensu stricto, C. scoticus, C. chiopterus.  
Ct values of positive pools in The Netherlands were lower than expected (compared to BTV). 
From testing individual Culicoides specimens in the Netherlands it became clear that 
prevalence of SBV in midges was 5-10 times higher when compared to BTV detection in 
Culicoides in Europe during 2002-2008. Vector biology was positively influenced by 
climatological circumstances in 2011 with a prolonged vector season (several weeks due to 
higher temperatures than normal) and a higher survival rate and  increased vector abundance 
(rain in summer and higher temperatures than normal in autumn) (Elbers et al., 2012).  
A field study executed outside this research consortium investigated the presence of SBV in 
mosquitoes overwintering at 11 ruminant farms in the Netherlands, where between November 
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2011 and January 2012 SBV circulation had been proven based on the presence of SBV RNA 
in the brains of malformed newborns (Scholte et al., 2014). No evidence was found for the 
presence of SBV in hibernating mosquitoes (Culex, Anopheles, and Culiseta spp.), collected 
from January to March 2012). It was suggested that mosquitoes do not play an important role, 
if any, in the persistence of SBV during the winter months in north-western Europe.  
 
Retrospective studies 2011, Belgium 
Pools of heads of several Culicoides species were found positive in qRT-PCR: Obsoletus 
complex, C. dewulfi and C. chiopterus, indicating that these species might play a role in the 
transmission and spread of SBV. The first SBV positive midges were found at August 23th 
2011 in the region of Liège. This represents till now the earliest detection of SBV in Belgium. 
Depending on time and place, a high percentage (up to 30%) of pools was found SBV 
positive. If it is considered that each positive pool contained one SBV positive midge, a high 
infection prevalence of 2.4% was found in Obsoletus complex midges in October in Liège. 
This high infection prevalence in Culicoides helps to explain the fast spread of the virus upon 
its emergence. No positive pools were found in the south of Belgium in 2011, correlating with 
a low seroprevalence rate in sheep and cows at the end of the first vector season (end 2011) in 
that region (De Regge et al, 2012). 
 
Retrospective studies 2011,Germany 
Culicoides pools and pools of black flies (Simuliidae) from 2011 in Germany tested negative 
for SBV.            
 
 
2.2.2 Prospective studies 
 
Methods: 
Netherlands prospective study 2012 
A total of 130 pools (50 specimens per pool) of Culicoides biting midges collected between 
May and September 2012 in the Netherlands were assayed for SBV (Elbers et al., 2014). The 
Culicoides midges were caught in the same area as where in 2011 a high proportion of 
Culicoides pools tested positive for SBV (Elbers et al., 2013).  
 
Germany prospective studies 2012-2013 
Insects were trapped by OVI (Onderstepoort Veterinary Institute) traps, BG-Sentinel biting 
midge traps, BG Sentinels and EVS traps between April and October 2013 at 38 collection 
sites in southern and eastern Germany (Fig 13.). Further insect samples collected between in 
2012 at 28 additional locations in western Germany within other projects were also made 
available for this study. Captured insects were pre-sorted and biting midges, in particular 
specimens of the genus Culicoides, were separated according to morphological features.  
By the end of 2013, realtime RT-PCR (Hoffmann et al. 2012) screening for SBV was 
conducted on 5,562 midges and 3 simuliids collected between May and October 2012 at 10 
locations in western Germany, respectively, as well as 10,840 midges plus 37 black flies 
sampled between May and October 2013 at 21 sites in southern and eastern Germany were 
tested. 
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Figure 13. Trap stations operated in the Schmallenberg project 
 
 
Belgian prospective study 2012 
 
Culicoides collected biweekly at 12 locations (divided over 4 regions) in Belgium with OVI 
(Onderstepoort Veterinary Institute) traps between July and November 2012 were 
morphologically identified and physiologically examined. Subgenus (Avaritia, Culicoides, 
Monoculicoides) specific pools of maximum 20 whole parous females were prepared. The 
RNA from these pools was extracted using the MagMAX Total Nucleic Acid isolation kit and 
the MagMAX Express-24 purification system. Obtained RNA was thereafter subjected to a 
qRT-PCR detecting the SBV-S segment. In total, 17461 midges divided over 904 pools were 
screened. Furthermore, 69 pools representing 1359 nulliparous midges caught in May in the 
region of Antwerp and Gembloux were tested by similar methods to assess a possible 
transovarial transmission. 
 
 
Results: 
Prospective studies, 2012-2013, Netherlands 
Two of  a total of 42 pools comprising 50 midges/pool of the Obsoletus Complex from the 
2012 collection, tested weak positive (Ct values: 34.96 and 37.66), indicating a relatively low 
viral load (Elbers et al., 2014). On an individual midge level, the proportion of SBV-infected 
Culicoides of the Obsoletus complex caught in the same area and in a comparable period of 
the year, was significantly lower in 2012 (0.1% = 1 per 1,050 tested) compared to 2011 
(0.56% = 13 per 2,300 tested). As a significantly lower proportion of SBV-infected 
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Culicoides was observed in 2012, it can be assumed that there was a lower level of circulation 
of SBV in this area in 2012.  The most obvious explanation for the lower level of SBV 
circulation in the field in 2012 is the fact that just a small fraction of hosts was left susceptible 
for infection after the massive epidemic in 2011. 
 
Prospective studies, 2012-2013, Germany 
Of all pools tested, only two appeared to be weakly positive for SBV with Ct values of 35 and 
42.46, respectively. Both pools consisted of Obsoletus Complex Culicoides (including C. 
dewulfi) and had been collected at two different locations in the federal state of North-Rhine 
Westphalia, western Germany, in late August and early September 2012. The pool sizes 
amounted to 20 and 22 midges per pool, respectively. None of the Simuliidae screened for 
SBV proved positive. In contrast to previous considerations, mosquitoes were not tested for 
SBV, due to negative results of other working groups (e.g. Scholte et al. 2014) combined with 
time constraints.  
 
Prospective studies, 2012-2013, Belgium 
No SBV could be detected in nulliparous midges caught in May 2012. This provides an 
indication that transovarial transmission is not likely to occur. This should, however, be 
further investigated since it was recently reported that SBV RNA was detected in midges 
considered as nulliparous based on visual inspection in Poland in 2012 (Larska et al,2013). 
A renewed but short lived circulation of SBV in parous midges belonging to the subgenus 
Avaritia occured in August 2012 at all four regions. The infection prevalence reached up to 
2.86% in the south of Belgium, the region where a lower seroprevalence was found at the end 
of 2011 than in the rest of the country. The infection prevalences in the other regions where 
positive pools were found in 2011 were markedly lower (0.4, 0.3, and 0.2% in Avaritia 
in Antwerp, Liège and Gembloux, respectively). No more positive pools were found from 
September onwards.  A frequency analysis of the Ct values obtained for 31 SBV-S segment 
positive pools of Avaritia midges showed a clear bimodal distribution with peaks of Ct values 
between 21-24 and 33-36. This closely resembles the laboratory results obtained for SBV 
infection of C. sonorensis and implicates indigenous midges belonging to the subgenus 
Avaritia as competent vectors for SBV (De Regge et al, 2014).    
 
 
2.2.3 Vector competence studies 
Methods: 
In this study, the group at the Laboratory of Entomology (Wageningen, The Netherlands) in 
collaboration with CVI (Lelystad, The Netherlands) inoculated five sheep intramuscularly 
with SBV and let suspected vector insects (Culicoides spp. and An. atroparvus mosquitoes) 
feed on the sheep during peak viraemia. Culicoides nubeculosus midges were reared 
according to a protocol developed by Boorman (1974), with minor modifications. The insects 
were reared at 23°C and 75% RH, and were fed daily on cattle blood through Hemotek FU1 
feeders (Hemotek, Accrington, UK) using a Parafilm® membrane (Bemis, Oshkosh, WI, 
USA). A. atroparvus mosquitos were reared under similar conditions according to a protocol 
developed by the rearing staff at the Laboratory of Entomology of Wageningen University. 
Wild Culicoides spp. midges were caught in May and June 2013 at a horse farm near 
Renkum, The Netherlands. Insects were ‘forced’ to feed on the sheep by placing known 
numbers of insects in small cardboard cages on the inner leg of the sheep. After exposure (i.e. 
blood feeding), the cardboard cages were detached from the sheep and insects were incubated 
at 25 °C to allow for the virus to replicate and disseminate within the arthropods. After the 
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incubation period the insects were killed, their heads separated, pooled and frozen until RNA 
extraction and PCR amplification. These experiments were carried out in the High 
Containment Unit (BSL-3) of the Central Veterinary Institute, Lelystad, part of Wageningen 
UR. 
 
Results: 
All five sheep showed the mild clinical symptom of raised body temperature (above 39.5°C) 
within the first five days after injection with SBV. SBV infection in the sheep could be 
confirmed by PCR of serum samples. All groups of insects (An. atroparvus, C. nubeculosus, 
field-collected Culicoides spp.) fed on all five sheep, albeit at different rates. C. nubeculosus 
showed the highest feeding rate (180/260, 71.5%), followed by An. atroparvus (18/60, 30.0%) 
and field-collected Culicoides spp. (5/754, 0.6%). In total, 1074 insects were applied to the 
sheep, of which 203 (18.9%) fed. Head pools of all three insect groups showed positive PCR 
bands for SBV S-segment fragment, but no individual insect abdomen. Positive pools 
included five pools of C. nubeculosus (30 individual heads in total) and one each from An. 
atroparvus (eight heads) and field-collected Culicoides sp. (one head). Positive signals were 
found in insects having fed on all five sheep between days 1 and 5 p.i.. Sequencing of 
amplified fragments from these seven positive head pools confirmed the identity of six out of 
seven samples as SBV S-segment. A BLAST search revealed 96-100% identity with the SBV 
strain NO/13/04/7678 segment S nucleocapsid protein and non-structural protein genes, 
partial cds (Access. no.: KF314813.1). We thus demonstrated for the first time a successful 
host-to-vector transmission of SBV and highlight the role of An. atroparvus mosquitoes as 
potential vectors. 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
36  
 
2.3  Role of semen and embryos 
 
2.3.1 RT-PCR testing of semen samples 
 
Methods and results: 
CODA-CERVA has tested 40 semen samples from sheep collected between summer and 
autumn 2011. None of these were tested positive by qRT-PCR. However no clear conclusions 
can be drawn since not sufficient data about the serological status of the animals was 
available. 
Schmallenberg virus has been detected in bovine semen using RT-PCR in Germany, France, 
UK and The Netherlands. By December 2012 within these countries 0-4% of recently 
produced semen batches were SBV positive by RT-PCR:  
By December 2012 at CVI a number of  55 semen samples produced in 2012 by 8 
seroconverting/viraemic bulls have been analysed using a real-time RT-PCR system 
developed by FLI and an RNA extraction method developed by CVI. In total 3 samples 
produced by 2 different bulls tested positive. 
By December 2012 LNCR (National Laboratory for sanitary controls in breeding animals) 
together with ANSES (Fr.), a number of 904 semen samples produced in 2011 and 2012 by 
160 seropositive bulls have been analysed using a real-time RT-PCR system developed by 
FLI and an RNA extraction method developed by LNCR.  In total 26 samples produced by 2 
different bulls were tested positive for 2 to 3 months. 
In Germany frozen semen collected between May 2012 and November 2012 from 95 
seroconverted bulls was analysed for SBV-RNA by real-time RT-PCR (RT-qPCR).  
A total of 766 semen batches from 95 SBV-infected bulls  were obtained from 7 stock-bull 
breeding centres in Germany in 2012. A total of 29 (3.8% of 766) semen batches from 11 
bulls from 3 breeding centres were positive in RT-qPCR analysis (see paragraph 3.2.1 for 
more details). 
 
 
2.3.2 Evaluation of transmission risks via embryos 
 
Methods: 
Evaluation of transmission risks via embryos were performed using different in vitro models 
with experimentally (in vitro spiking) or naturally infected oocytes or semen (LNCR). 
Efficiency of sanitary washes recommended by (International Embryo transfer Society (IETS) 
was tested in each model following in vitro maturation, fertilization and culture. Zygotes, 
embryos, media and washes were tested for SBV RNA using RT PCR.  
 
Results: 
Fertilization of in vivo contaminated gametes leaded to produce contaminated zygotes, 
however D7 embryos following IETS washing protocols were negative regarding SBV RNA. 
At the contrary, in vitro spiked gametes resulted in contaminated embryos and IETS washing 
procedure was inefficient to remove SBV RNA. This may be explained by higher doses of 
virus during spiking or different properties of cultured viruses regarding interaction between 
virus and the embryo zona pellucida. All together, these results suggest that naturally infected 
gametes (oocytes / semen) may be associated with a negligible risk of transmission through in 
vitro produced embryos. However, the results using in vitro spiking approaches were not in 
agreement with the in vivo contamination models. The mechanisms involved in the 
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differences observed between both models remain to be explained. Additional data on in vivo 
derived embryos are needed. 
 
 
2.3.3 Studies on in vitro embryo (from cattle) production and efficiency of IETS 
washing procedures 
 
Methods: 
Evaluation of transmission risks via embryos were performed using different in vitro models 
with experimentally (in vitro spiking) or naturally infected oocytes or semen. Efficiency of 
sanitary washes recommended by IETS was tested in each model following in vitro 
maturation, fertilization and culture. Zygotes, embryos, media and washes were tested for 
SBV RNA using RT PCR. Results are summarized in Table 6.  
 
Results: 
Fertilization of in vivo contaminated gametes leaded to produce contaminated zygotes, 
however D7 embryos following IETS washing protocols were negative regarding SBV RNA. 
At the contrary, in vitro spiked gametes resulted in contaminated embryos and IETS washing 
procedure was inefficient to remove SBV RNA in this case. This may be explained by higher 
doses of virus during spiking or different properties of cultured viruses regarding interaction 
between virus and the embryo zona pellucida.  
 
Table 6. In vitro produced embryos following in vitro spiking of gametes (oocytes and semen) or issued from 
naturally infected gametes 
In vitro produced 
embryos 
Semen 
Negative samples 
Semen 
In vitro spiking 
Semen  - In vivo 
contamination 
Oocytes 
Negative samples 
Control group Inefficient IETS washing Positive  zygotes 
Negative embryos 
following IETS washing 
Oocytes 
In vitro spiking 
Inefficient IETS 
washing 
x x 
Oocytes 
In vivo 
contamination 
Positive oocytes 
Negative embryos 
following IVP 
x x 
 
 
All together, these results suggest that naturally infected gametes (oocytes / semen) may be 
associated with a negligible risk of transmission through in vitro produced embryos. 
However, the results using in vitro spiking approaches were not in agreement with the in vivo 
contamination models. The mechanisms involved in the differences observed between both 
models remain to be explained. Additional data on in vivo derived embryos are needed. 
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2.3.4 Experimental infection of bulls to investigate SBV excretion in semen 
 
To study Schmallenberg virus excretion in bovine semen after experimental infection, two 
bulls were inoculated subcutaneously with a Schmallenberg virus isolate (1ml Vero cell 
culture 10E6 TCID50). After inoculation (at Day 0), semen was collected daily from both 
animals for 21 days and samples were tested for Schmallenberg virus by qRT-PCR assay. At 
24 days after inoculation both animals were subjected to necropsy and genital organs and 
lymph nodes draining these organs were also tested for Schmallenberg virus RNA ( qRT-
PCR). After SBV infection both animals in the study showed viraemia (qRT-PCR) with fever 
and diarrhoea. Schmallenberg virus RNA could be detected in semen from both animals. 
Schmallenberg virus RNA was detected with the highest levels in the period of Day 4 to Day 
7 after inoculation (Figure 14.), five consecutive days in one bull and at one occasion in the 
other. Scattered low concentration positives were found in week two and three after 
inoculation in single amplification runs. Schmallenberg virus RNA was not detected in the 
genital tissues after necropsy but SBV RNA was detected in the mesenteric and inguinal 
lymph nodes draining these tissues. SBV RNA concentrations in semen samples were 
relatively low (Ct-values 30-39). SBV RNA concentrations were higher in whole blood and 
serum (Day 2 to Day 4; CT-values 27-31) and in the lymph nodes (Day 24; Ct-values 29-39). 
Schmallenberg virus was only isolated in cell cultures from blood samples at Day 3 after 
inoculation. Schmallenberg virus could not be isolated in Vero cells from any of the semen 
samples or the tissue samples.  
 
The observations from this study indicate that Schmallenberg virus RNA can be excreted in 
bovine semen. This suggests that bovine semen might be contaminated with viable virus. 
Although viable virus was not detected in semen in this study, in an earlier study by others, 
infectivity of semen from SBV RNA positive straws was reported after subcutaneous 
injection in calves, even in specimens with relatively low concentrations of SBV RNA. To 
exclude that SBV RNA is present in produced semen, highly sensitive RT-PCR-testing of 
semen from SBV-infected (RNA or antibody positive) bulls is the method of choice 
(Hoffmann et al., 2013; Schulz et al., 2014). However, at present it is not clear if the detected 
low concentrations of SBV RNA will be associated with infectious virus. Moreover, even in 
case of contamination of semen with infectious Schmallenberg virus it still needs to be 
elucidated if infectious virus can be transmitted to susceptible cows at service or by 
insemination. A study on Schmallenberg virus infection after insemination with qRT-PCR 
positive semen straws will be needed to answer this question. 
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Figure 14. Schmallenberg virus RNA detection (RT-qPCR values) in semen samples collected from two 
experimentally infected bulls from Day 0 until Day 21 after inoculation. Semen samples with extender (1:10 
tris/egg yolk 20%). 
 
 
2.3.5 Experimental infection of cattle and IFNAR
-/-
 mice with SBV-RNA-positive 
bovine semen 
 
Methods: 
In the previous field study, SBV-RNA was detected in frozen bull semen by real-time RT-
PCR (RT-qPCR). Vectorborne transmission by Culicoides spp. biting midges is most 
common, but venereal transmission of SBV might contribute to the spread of this virus to 
previously unaffected regions. Therefore, the infectivity of SBV-RNA–positive semen was 
investigated by experimental subcutaneous injection of cattle and interferon α/β receptor–
deficient (IFNAR
-/-
) mice. 
 
Experimental infection of cattle with SBV-RNA positive semen, Germany 
The straws originating from 6 semen batches (Cq 26.4-36.4) collected from 6 bulls (A-C and 
E-G) during August and September 2012 (Hoffmann et al. 2013). To increase the probability 
of infection of injected cattle, 5 straws of semen from one batch from an individual bull were 
pooled, and 6 cattle (C1-C6) were subcutaneously (s.c.) inoculated, each with a pool from 1 of 
the 6 bulls. To investigate the infectivity of a single insemination dose (1 straw), 5 cattle (C7-
C11) were s.c. injected with single straws from bull F that had been confirmed to contain 
infectious SBV (by s.c. inoculation of calves). Serum samples were obtained in several days 
(Figure 15) and tested for SBV-RNA and antibodies by small-segment-specific RT-qPCR, 
ELISA and neutralization test, respectively. Clinical signs and rectal body temperatures for 
the injected cattle were monitored daily.  
 
Experimental infection of IFNAR
-/-
 mice with SBV-RNA-positive semen 
A total of 20 SBV-RNA-positive semen batches (Cq-values 25.9-36.5) collected from bulls 
during August to November 2012 (Hoffmann et al., 2013) were subcutaneously injected into 
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40 IFNAR
-/-
 mice. For each batch, two mice were each injected with half of a semen straw 
(80-120µl). The mice were monitored clinically and weighed daily. Serum and tissue samples 
were harvested post-mortem at 22 dpi and tested for SBV antibodies and genome by ELISA 
and SBV-S3-specific RT-qPCR, respectively.  
 
Results: 
SBV infection was confirmed in 5 of 11 injected cattle (C3, C5 and C9-C11). RNAemia (Cq 
25.0-29.3) was first detected at 3 to 6 days post-infection (dpi) and persisted for 3 to 4 days. 
Seroconversion occurred between 8 and 12 dpi (Figure 15). No obvious clinical signs were 
observed in any of the cattle (Schulz et al., 2014). 
In none of the mice, SBV-RNA or antibodies were detected (Schulz et al., 2014).  
 
 
Figure 15. Detection of Schmallenberg virus (SBV) RNA and antibodies in serum of 5 of 11 cattle (C) injected 
with SBV RNA–positive bovine semen (quantification cycle [Cq] values 26.4–36.4) (Schulz et al., 2014).  
 
We demonstrated that subcutaneous injection of a single insemination dose of SBV-RNA-
positive semen can be infectious for cattle, although not every straw of the same batch was 
infectious. Possible explanations are that infectivity of individual straws does not correlate 
with the viral RNA load or that the infectivity of one straw is lower than the minimal cattle 
infectious dose for SBV. IFNAR
-/-
 mice were not infected with SBV, which might be due to a 
lower susceptibility to SBV infection compared to cattle. Despite the possibility of infective 
SBV in some semen batches, the actual risk for SBV transmission by insemination of dams 
remains to be evaluated. To exclude that SBV RNA is present in produced semen, highly 
sensitive RT-PCR-testing of semen from SBV-infected (RNA or antibody positive) bulls is 
the method of choice (Hoffmann et al., 2013; Schulz et al., 2014). 
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Experimental infection of IFNAR
-/-
 mice with SBV-RNA-positive semen, France 
Methods: 
In France (LNCR), seven bulls, 1 to 5 years of age, with no SBV detectable neutralizing 
antibodies prior to the beginning of the study were selected with the following criteria: SBV 
seroconversion observed between September 2011 and December 2012 and the most 
complete semen production batches including at least 14 ejaculates, collected from 4 weeks 
before to 4 weeks after the first positive SBV ELISA result. Semen was collected once or 
twice a week, diluted, conditioned in straws and frozen using classical procedure. 
From each ejaculate collected from one month following seroconversion, one straw was tested 
for the presence of SBV RNA by one-step real time RT-PCR (rtRT-PCR) method by LNCR.  
For each bull, the presence of SBV specific antibodies was tested monthly in serum using an 
indirect ELISA kit.  
The presence of infectious SBV in semen was appreciated by inoculating IFNAR
-/-
 mice 
(ANSES). Three semen replicates (each 100 µl) from one single ejaculate, first batch 
presenting low Ct value (Ct = 25.4) results were injected into the neck scruff of three adult 
IFNAR
-/-
 mice. After 4 days, EDTA blood samples were tested by SBV RT-PCR (ANSES). 
 
Results:  
All the seven bulls presented a SBV seroconversion by ELISA. From 83 ejaculates, no SBV 
RNA was detected in four bulls (bulls 2, 3, 4, 6) before and following seroconversion. 
However, three bulls (1,5 and 7) from different breeds (Holstein or Normand) were found 
SBV RNA positive on more occasions using rtRT-PCR (Figure 16 A, B and C). 
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To confirm that bull semen contains infectious SBV and that semen keeps infectivity even 
after bull seroconversion, we performed additional in vivo experimental infections using the 
IFNAR
-/-
 mice model. 
 
In a first experiment, we showed that 100 µl of semen replicates from one SBV RNA positive 
ejaculate (bull 7 sampled on 29/08/2012; SBV Ct value =17.1) induced a viremia in three 
adult mice (Ct-values ranged between 23 to 28.9) and that they seroconverted within 3 weeks 
following infection.  
To improve these results, a second in vivo assay were performed, involving four groups of 
four IFNAR-/- mice inoculated again with the same semen batch as well as semen samples 
collected before or after this date. Results are summarized in table 7 (see below). 
Again, all four mice inoculated with the semen batch from the 29/08/2012 displayed high 
SBV RNA levels in IFNAR
-/-
 blood 4 days p.i. (Ct-values ranged between 20 to 26) and were 
SBV ELISA positive 3 weeks p.i. Inoculation of the semen from 07/09/2012 induced low 
SBV RNA and antibody levels in two out of four mice, while SBV RNA and antibodies 
remained undetectable in all mice upon inoculation with the semen from 17/09/2012. 
Interestingly, the semen collected the 24/08/2012 induced positive SBV Ct value in only two 
mice but without detectable SBV antibody by ELISA. It is noteworthy that all mice with no 
detectable SBV RNA 4 days p.i. have also no detectable SBV antibody in serum, suggesting 
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that a viraemia seems to be required to induce a humoral response upon inoculation with 
naturally SBV RNA positive semen. This is in favor of the presence of a replicative virus in 
the inoculum. 
Finally, positive SBV blood samples collected from mice at day 4 p.i. with semen from 
29/08/2012 during experiment 2 were pooled (Inoculum A) and subsequently diluted 1 to 10 
or 1 to 100 in MEM medium. Two groups of four mice were inoculated with 100 µl of these 
two blood preparations (experiment 3). Among all inoculated animals, one mouse was found 
SBV qRT-PCR and ELISA positive when inoculated with the IFNAR blood diluted 1/10. 
This indicates that the SBV RT-PCR positive IFNAR-/- blood collected at 4 days p.i. with the 
semen from 29/08/2012 (experiment 2) and inoculated to new IFNAR-/- mice (experiment 3), 
contained infectious material at probably low level but sufficient to induce SBV viraemia and  
seroconversion in at least one mouse. 
 
 
Table 7. Ct values and seroconversion results in blood mice inoculated with SBV positive bull semen or IFNAR 
blood. 
 
 
Inoculum Exp. N° Mice N°
Ct 
inoculum
Ct blood
(4 days p.i.)
ELISA 
results
8587 36.7 Neg
8585 Neg Neg
8589 24.0 Neg
8581 Neg Neg
7728 28.9 Pos
8216 23.5 Pos
8410 23.0 Pos
8583 21.7 Pos
8849 20.0 Pos
8582 25.6 Pos
8588 26.0 Pos
8827 31.5 Pos
8571 Neg Neg
8847 Neg Neg
8856 37.0 Pos
8621 Neg Neg
8709 Neg Neg
8853 Neg Neg
8630 Neg Neg
8631 22.1 Pos
8634 Neg Neg
8858 Neg Neg
8629 Neg Neg
8688 Neg Neg
8682 Neg Neg
8848 Neg Neg
8625 Neg Neg
3
2
2
2
1
2
Inoculum A
(1/100)
Inoculum A
(1/10)
Bull 7
(17/09/2012)
Bull 7
(07/09/2012)
Bull 7
(29/08/2012)
Bull 7
(24/08/2012)
3
19.7
17.1
33.6
25.0
22.0
23.1
22.3
 
Conclusion: 
All together, these results strongly suggest that semen batches collected the 29/08/2012 and 
the 07/09/2012 contained infectious SBV. 
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2.4  Determination of the role of other species in the epidemiology of SBV  
 
2.4.1 Experimental infection in pigs 
 
Methods: 
An experimental infection study in pigs was performed at CODA-CERVA. Four 12 week old 
seronegative piglets were subcutaneously infected with 1ml of SBV infectious serum (FLI) 
and kept into contact with four non-infected piglets to examine direct virus transmission. 
Throughout the experiment blood, swabs and feces samples were collected and upon 
euthanasia at 28 dpi different organs (cerebrum, cerebellum, brain stem, lung, liver, iliac 
lymph nodes, kidney and spleen) were sampled. The presence of SBV RNA was examined by 
a qRT-PCR detecting the SBV-S segment and the presence of anti-SBV antibodies was 
assessed by seroneutralisation tests and ELISA.  
Furthermore, field collected pig sera from before (n=109) and after (n=106) the SBV outbreak 
was tested in a seroneutralisation test. 
 
Results: 
No clinical impact was observed in the SBV inoculated pigs. Also all collected samples tested 
negative for SBV in rRT-PCR. Despite the absence of viremia and SBV in organs and, low 
and short lasting amounts of neutralizing antibodies were found in 2 out of 4 infected piglets. 
In ELISA, all samples tested negative. This is in line with results in sheep that show that the 
multi species ELISA (IDVet) is less sensitive at early time points post infection, and probably 
indicates that the first produced neutralizing antibodies are of the IgM isotype, which are not 
detected by the anti-IgG conjugate in the ELISA. The limited impact of SBV infection in pigs 
was further supported by the absence of neutralizing anti-SBV antibodies in field collected 
sera from indoor housed domestic pigs collected after the SBV emergence. In conclusion, 
SBV infection of pigs can induce a transient seroconversion but is ineffective in terms of virus 
replication and transmission indicating that pigs have no obvious role in the SBV 
epidemiology (Poskin et al, 2014).   
 
 
 
2.4.2 Studies of SBV infection in South American camelids 
 
Serological evidence of a previous SBV-infection demonstrated the susceptibility of South 
American camelids (SAC) to SBV. However, SBV pathogenesis in SAC and their role in the 
epidemiology of SBV are unknown. SAC become increasingly popular, and their current 
population is estimated to be 15,000 animals in Germany. Therefore, a field study and an 
animal trial were conducted. Furthermore, reference material was collected from 
experimentally infected SAC to validate serological and virological assays for SBV diagnosis 
in SAC. 
 
German field study of SBV infection in South American camelids 
 
Methods: 
To investigate the incidence and clinical outcome of SBV infection in SAC, a field study was 
carried out in Germany from September 2012 to December 2013. SAC owners, veterinary 
laboratories and universities were contacted to submit blood and post-mortem samples and to 
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document clinical signs, malformations and abortions in SAC and their offspring (“cria”) in a 
provided questionnaire.  
Blood and post-mortem samples were analysed for SBV-RNA and antibodies using ELISA, 
neutralisation test and SBV-S3-specific RT-qPCR, respectively. SAC were considered SBV-
seropositive or doubtful when at least one serological test result (ELISA or neutralisation test) 
was positive or doubtful. The serological results analysed by neutralisation test were 
compared with those determined by ELISA.  
 
Results: 
Blood samples from 502 SAC from 66 herds in 11 of 16 federal states were collected in 
Germany from September 2012 until December 2013. The overall sample size was higher 
than the sample size required to detect a seroprevalence of 10 to 90% with a confidence level 
of 95% and an accepted error of 5% (Conraths et al., 2011), and is therefore considered 
representative for the German SAC population.  
SBV antibodies (n=309 seropositive, n=4 doubtful) were found in two-thirds (62.4%) of 502 
SAC in 61 of the 66 herds (92.4%). The within-herd seroprevalence ranged from 0 to 100%, 
and the proportion of seropositive animals by federal state from 31 to 100%.  
The age-group was provided for 277 SAC of which 67.1% were found seropositive. Of these 
SAC, a considerably lower proportion of crias (25.6%) were SBV seropositive compared to 1 
to 2-year-old juveniles (78.0%) and >2 year-old adults (73.9%). In contrast to the high SBV 
seroprevalence, no SBV-RNA was detected in any sample.  
Clinical signs were not reported in any SAC tested in this study. A total of three malformed 
crias were reported, but SBV infection could not be confirmed to be the cause of the 
malformations in any of the cases. An increase in the number of malformed or aborted crias in 
Germany was not recorded in this study.  
A significantly (p < 0.01) higher number of animals was tested seropositive with 
neutralisation test compared with ELISA and a few animals only tested positive with ELISA.  
 
 
SBV pathogenesis in South American camelids experimentally infected with SBV 
 
Methods: 
Three llamas (lama glama) and two alpacas (Vicugna pacos) were purchased from breeders in 
Germany and were tested negative for SBV-RNA and antibodies before their transfer to the 
high containment facility of the FLI, Isle of Riems. All SAC were experimentally infected 
with SBV-containing serum well characterised by previous animal trials (Wernike et al., 
2012). Clinical signs and fever were monitored daily. Serum was collected at -1, 2 to 7, 9, 11, 
14, 17, 21, 28, 40, 47 and 54 dpi, and post-mortem examination was conducted at 62 dpi. 
Post-mortem samples included spleen, liver, mesenteric and mediastinal lymph nodes, tonsils, 
cerebrum, cerebellum and medulla oblongata. Serum samples of all SAC were comparatively 
analysed for SBV antibodies with ELISA and neutralisation test. Serum and post-mortem 
samples were tested by S-segment-specific RT-qPCR.  
 
Results 
No obvious clinical signs were observed in any of the 5 SAC. SBV-RNA was detected from 3 
to 7 dpi for a period of 1 to 5 days with peak Cq-values between 24.0 and 41.6 (average Cq 
30.2). Seroconversion occurred between 9 and 21 dpi and between 9 and 40 dpi as measured 
by neutralisation test and ELISA, respectively. A considerable increase of SBV antibody 
levels below the cut-off values of the ELISA was observed in all animals at 14 dpi compared 
to -1 dpi; at a time when all except one SAC were seropositive by neutralisation test. The 
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detection of SBV antibodies in SAC serum was found more sensitive using neutralisation test 
compared to ELISA, which is in accordance with the results of the field study. At post-
mortem examination, at day 62 p.i.,none of the SAC showed gross pathological lesions. SBV-
RNA was detected in the spleen of L1 (Cq 39.7), but not in any other tissue sample.  
 
The overall and within-herd SBV seroprevalence found for SAC was lower compared to SBV 
seroprevalence reported for cattle and sheep, but higher than in goats and Alpine wild 
ungulates. Interestingly, a lower within-herd seroprevalence was found in SAC in North-
Western German federal states - the federal state that recorded a high number of new SBV 
cases in domestic ruminants between 2011 and 2012. This contrasts the higher seroprevalence 
in SAC herds found in South-Eastern Germany where most of the SBV cases were reported in 
2013. A possible reason might be that SBV antibodies do not persist for a long time in SAC 
after SBV infection. No SBV-RNA was detected in any sample, which was probably due to a 
short-time viraemia (as observed in the animal trial) and the period of sample collection - after 
the peak of SBV infections in 2011. 
The low proportion of SBV-infected crias can be explained by the lower number of SBV 
infections reported during the study period compared to the number of new infections 
reported in domestic ruminants from 2011 to summer 2012 in Germany.  
Serological and virological methods for SBV diagnosis in SAC that were validated with the 
specimens collected from SAC experimentally infected with SBV were found suitable for 
SBV diagnosis in SAC. Based on the serological results of the field study and animal trial, we 
recommend to use ELISA or neutralisation test for herd screening, but a combination of both 
methods for diagnosis of SBV antibodies in individual SAC. 
 
Similar to SBV-infected ruminants, SBV genome can be detected in SAC for a short time 
after SBV-infection. The results of the field study and animal trial indicate that SAC are 
resistant to SB disease, but their role in the epidemiology of SBV has to be further 
investigated. 
 
 
2.4.3 Experimental infection in poultry 
 
Experimental Simbuvirus infection of poultry were performed at FLI. 6 groups of 4 chickens 
each were inoculated with Sabo virus, Simbu virus, Sathuperi virus, Schmallenberg virus 
(challenge serum), Schmallenberg virus (cell culture propagated virus) and cell culture 
medium (negative control animals). 
 
None of the chickens showed specific clinical signs. All samples collected on several days  
post inoculation were SBV genome negative (RT-qPCR). Furthermore, the inoculated 
chickens produced no virus specific antibodies. In conclusion, also chicken are not susceptible 
for Simbu, Sabo, Sathuperi and Schmallenberg virus. 
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2.5 Determination of the role of wildlife (deer, wild boar etc.) in the epidemiology of 
Schmallenberg virus (SBV) 
 
2.5.1 Wildlife in Germany 
 
Methods: 
In 2011 Schmallenberg virus (SBV) was first detected in domestic ruminants i.e. cattle and 
sheep. Moufflon as a wild sheep is the only free-living wild form of susceptible domestic 
animals in Germany. To identify native wildlife species in Germany that are infected with 
SBV, blood samples were collected from following species: (1) Moufflon, (2) further native 
free-living ruminants (roe deer, fallow deer, red deer, sika deer); (3) wild boar (which belong 
to the closely related Suidae family within the Artiodactyla order); (4) carnivores (foxes, 
raccoon dogs, raccoons, marten spp. etc.) as scavenger, which could be in contact with SBV 
eating aborted fetuses and stillborn and distorted newborn fawns; (5) mice as a potential 
reservoir for SBV.  
The sample collection was selected on the basis of the first detected cases in Germany 
(11/2011) in periods a) before 2011, b) during the peak of the SBV epizootic (hunting period 
2011/2012) and c) current situation (hunting period 2012/2013). 
To determine date and place of SBV emergence in wildlife, we analysed historical samples 
collected from wild ruminants in North Rhine-Westphalia before 2011. 
Furthermore, during the hunting season 2013 /2014 (beginning 1st April 2013) the sample 
collection was limited to North Rhine-Westphalia, the federal state where the first case of 
SBV infection was detected. To detect possible new SBV infections in autumn 2013 - at a 
time when maternal immunity has most likely ceased - we focused on samples from subadults 
< 1 year of age (fawns, calves, lambs and young boars). 
SBV antibodies were analyzed with ELISA. Sera with a serological status defined as doubtful 
or negative were retested by neutralization test. A representative number of samples with 
positive ELISA-results from each species were confirmed by serum neutralization test. In this 
section, doubtful results are referred to as ‘positive’. 
 
Results: 
A total of 27.7% of 1868 blood samples collected from moufflons (72% of 29), roe deer (42% 
of 499), fallow deer (36% of 44), red deer (29% of 226), sika deer (25% of 20) and wild boar 
(21% of 1079) between 2011 and 2013 were positive for SBV antibodies. In contrast, the 
proportion of seropositive animals was considerable lower in samples collected in North 
Rhine-Westphalia in 2013/2014 (10.5% of 702: 30% of 10 moufflons, 27% of 229 roe deer, 
12% of 43 fallow deer, 0% of 51 red deer, 4% of 369 wild boar) compared to 2011-2013. In 
the study period 2013/2014, no samples were obtained from sika deer. For subadults tested in 
autumn 2013 and January 2014, 10 (moufflons, fallow deer, red deer, wild boar) and 1 (red 
deer), respectively, were found seropositive.  
No SBV antibodies were detected in 788 historical samples collected before 2011 and in 281 
wild carnivores and 195 mice collected from 2011 to 2012. 
For 80 samples that were retested with neutralization test, about twice as much were positive 
by neutralization test (n=33) but negative or doubtful with ELISA. A disagreement between 
the two test systems was particularly found for red deer (18 of 19 only positive with 
neutralization test). These results suggest that seroprevalence given for red deer and wild boar 
for the study period 2011-2013 might be higher since the samples were only tested with 
ELISA. 
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In addition to wild cervids, wild boars were found SBV seropositive indicating that not only 
ruminants and camelids but also other members of the Artiodactyla order are susceptible to 
SBV infection. Hence, free-ranging Artiodactyla, but not mice or wild carnivores, might play 
a role as reservoir in the epidemiology of SBV. During the last three years the rate of 
seropositive wild ruminants as well as wild boar in North Rhine-Westphalia increased from 
autumn 2011 to winter 2012/2013 and decreased in summer 2013 indicating that a small 
number of new SBV infections have occurred in subadults in autumn/winter 2013/2014. 
Currently, the low level of SBV-specific immunity in wild cervid and wild boar populations 
in North Rhine-Westphalia is low.  Further investigation in the next years would show 
whether a low level of SBV infection in the population will persist (a low number of new 
infected young animals each year) or possibly lead to a new peak of SBV infection in wild 
ruminants and wild boar populations. To compare the spread of SBV in domestic and wild 
animals, seroprevalence of both populations has to be investigated in the same region. 
 
 
2.5.2 Wildlife in France 
 
Methods: 
ANSES was involved in epidemiological studies performed in France in wild ruminant (deer) 
but also in a non-ruminant species (dog). Retrospective serological studies performed on sera 
collected during the SBV spread in France were conducted. 
 
Results:  
Our data suggest also that SBV spread very quickly from north-eastern to south-western 
France between October and December 2011 (800 km). They also put in evidence that SBV 
spread among red deers and domestic flocks at the level of the department, and highlight the 
perspective of that red deers could be sentinels of SBV spreading for livestock. We also 
pinpointed the relevance of new competition ELISA for improving SBV surveillance in 
wildlife species, even though SNT remained the most reliable assay for SBV antibody 
detection in red deers.  
More interestingly, following neurologic disorders detected in five 15-day-old puppies 
(Belgian shepherd) from a dog breeding kennel in northwestern France (Orne), we report data 
suggesting that these puppies were infected with SBV. The presence of specific SBV 
antibodies in the mother associated with congenital symptoms and the presence of SBV 
genome in her puppy suggested that these dogs experienced SBV infection. In addition, the 
fact that the malformed puppies were born in March 2012 and that SBV antibodies were still 
detectable in the mother in March 2013 suggests that the duration of SBV antibodies in dogs 
is at least one year. 
 
 
2.5.3 Wildlife in the Netherlands 
 
Schmallenberg virus antibody screening in wildlife in the Netherlands was focussed on 
Fallow deer, roe deer and wild boar. High seroprevalences were observed in Fallow deer 
(42%), roe deer (46%) and wild boar (22%).  
 
Schmallenberg virus antibody prevalences observed in the different countries for the most 
abundant wildlife species were largely in agreement. 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
49  
 
2.5.4 Schmallenberg virus antibody testing in horses and zoos in the United Kingdom 
 
Methods:  
Serum samples were collected from horse holdings in regions heavily affected by the initial 
outbreak in the UK. In total 92 horses were tested using both ELISA and VNT format. SBV-
specific antibodies could not be determined in any horse, making an infection of equids 
unlikely.  
 
Furthermore, serum samples were opportunistically collected two zoos in the UK. In the first 
case, 180 samples from 01/01/2011 and 01/02/2014 representing  38 different species were 
tested using a competitive ELISA (Table below) and 29 samples of 17 different species were 
tested using PRNT for confirmation.  
 
Order Species- Latin name Species – common name 
Sample
s (n) 
Different 
individual
s 
Artiodactyla 
Vicugnapacos Alpaca 1 1 
Bison bison American bison 1 1 
Oryx leucoryx Arabian oryx 4 4 
Axis axis Axis deer 1 1 
Camelusbactrianus Bactrian camel 6 6 
Antilopecervicapra Blackbuck 1 1 
Tragelaphuseurycerus Bongo 4 3 
Hydropotesinermis Chinese water deer 1 1 
Bison bonasus European bison 9 7 
Damadama Fallow deer 1 1 
Bosgaurus Gaur 2 2 
Oryx gazellagazella Gemsbok 10 6 
Tragelaphusstrepsiceros Greater kudu 6 3 
Axis / Hyelaphusporcinus Hog deer 3 2 
Aepycerosmelampus Impala 2 2 
Lama glama Llama 3 2 
Alcesalces Moose 5 3 
Kobus megaceros Nile lechwe 4 2 
Capra aegagrushircus Nubian goat 3 3 
Elaphurusdavidianus Pere David's deer 4 4 
Hexaprotodonliberiensis Pygmy hippo 3 1 
Potamochoerusporcus Red river hog 2 2 
Rangifertarandus Reindeer 1 1 
Giraffacamelopardalisretic
ulata 
Reticulated giraffe 4 3 
Oryx dammah Scimitar-horned oryx 16 12 
Tragelaphusspekii Sitatunga 14 10 
Rucervusduvaucelii Swamp deer 4 4 
Kobus ellipsiprymnus Waterbuck 2 2 
Capra aegagrushircus White Windsor goat 1 1 
Bosgrunniens Yak 21 10 
Perissodactyla 
Equusafricanusasinus Domestic donkey 2 2 
Equusgrevyi Grevy's zebra 13 6 
Rhinoceros unicornis Indian rhinoceros 2 2 
Equushemionus Onager 8 5 
Equusasinuspoitou Poitou donkey 2 2 
Equusferusprzewalskii Przewalski horse 5 2 
Equusferuscaballus Shetland pony 2 2 
Ceratotheriumsimum White rhinoceros 4 4 
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In addition 28 samples from a second zoo representing 16 different species were assayed 
using the competitive ELISA. 
Furthermore, tissue samples of two newborn yak were screened using PCR. 
 
Results: 
Positive SBV competitive ELISA results from samples from zoo 1 and zoo 2 are detailed 
below. The ELISA was positive in samples representing 14 species from zoo 1 and in eight 
samples from eight individuals representing seven species from zoo 2 (Table 9).  
 
ZOO 1 
Species - common 
name 
Individual Samples 
Bongo X             
European bison X X X           
Gaur X             
Gemsbok X             
Greater kudu X X X           
Grevy's zebra X             
Moose X X            
Nile lechwe X X            
Nubian goat X             
Onager X             
Reindeer X             
Scimitar-horned oryx X X X X X X X X X X X   
Sitatunga X X X X X X X       
Yak X X X X X X X X X X    
ZOO 2 
Species - common 
name 
Individual Sample  S/N results 
Babirusa X             
Banteng X             
Bongo X             
Congo buffalo X X            
P.S. deer X             
Roan antelope X             
Scimitar-horned oryx X             
 
Table 9. Positive SBV competitive ELISA samples both  zoos  
 
 
PRNT was carried out and confirmed the validity of (both positive and negative) ELISA 
results for deer (hog deer, reindeer), antelope (Greater kudu, blackbuck), bovids (yak, gaur,) 
giraffes and red river hogs. An ELISA inconclusive white rhinoceros was negative on PRNT, 
further confirming the notion that the infection is limited to ruminants (and possibly some pig 
species). Two camelids (Bactrian camel, llama) that showed a negative, but suspicious ELISA 
results were positive on PRNT.  
 
In addition fetal Yak tissues were confirmed to be SBV positive by PCR demonstrating that 
this species can be clinically affected too. 
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Area 3 : Diagnostics 
 
Main objectives 
To harmonise the validation of RT-PCR methods for the detection of SBV and to harmonise 
the validation of SBV serological assays. 
Workplan (concise) 
All partners of the consortium were using a diagnostic RT-PCR targeting the SBV S-segment.  
To asses RT-PCR diagnostic procedures in the different labs, an interlaboratory comparison 
study of RT-PCR diagnostics was performed. In all partner laboratories tests were done using 
the routine procedure of the lab. Sample processing procedures as well as SBV RNA 
extraction procedures were included in this comparison study.  
 
Among partners there was no common protocol for validation of serological tests. Based on 
currently used methods some minimum criteria for validation of SBV serology were listed. A 
limited inter-laboratory ring trial for serology was organised by CVI.  
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3.1 Harmonisation and validation of serologic tests 
Methods: 
For SBV antibody detection laboratories first implemented virus neutralization tests (VNTs) 
and later on SBV ELISAs. In order to obtain a first impression of laboratory performances in 
SBV antibody testing in Europe a simple and straightforward inter-laboratory ring trial was 
organised in June 2012. A set of 10 SBV antibody positive and negative sheep and cattle sera 
was circulated among eight different veterinary laboratories in 7 countries in Europe. The 
eight laboratories in the trial all together used 6 different assays for Schmallenberg virus 
antibody detection. Besides a virus neutralization test (VNT), three laboratories performed an 
in-house ELISA and six laboratories used one or more commercially available ELISAs.  All 
test results were reported to the organising laboratory for comparison. 
Results: 
Schmallenberg virus antibody test results by VNT were in agreement for eight participating 
veterinary laboratories in the ring trial. ELISA assays by these eight laboratories performed 
well but some test results had to be designated as ‘doubtful’ by some labs whereas these 
samples were mainly scored positive by other labs. VNT was more sensitive in detecting SBV 
specific antibodies than some of the used ELISA assays. Eight veterinary laboratories within 
the ring trial performed  a virus neutralization test (VNT) as well as one or two ELISAs  on a 
set of 10 ruminant serum samples, and swiftly detected SBV antibodies using these assays.  
VNT was more sensitive in detecting SBV specific antibodies than some of the used ELISA 
assays. Based on the test results one cattle and one sheep SBV antibody positive serum were 
selected to serve as reference sera, which now can be supplied to other laboratories on 
request. 
The ring trial gave a good first impression of routine SBV serology in European veterinary 
laboratories and the results were promising for VNT as well as for ELISAs. VNT results were 
in agreement between laboratories. For ELISA results there were some discrepancies but in 
general these assays also performed well. The study gave an impression of the sensitivity and 
the specificity of SBV antibody detection assays in different laboratories, but it has to be 
taken into account that a very limited number of samples was tested in this trial. To assess 
sensitivity and specificity of ELISAs a much larger and more varied set of samples will have 
to be tested. It can be concluded that Schmallenberg virus antibody detection in the different 
veterinary laboratories within EU is reliable. Based on the results of the study one SBV 
antibody positive cattle serum  and one SBV antibody positive sheep serum were selected to 
serve as reference sera, which now can be supplied to other laboratories on request. 
 
3.1.1 Further validation of serologic tests 
 
In extension to the first ring trial comparing ELISA and VNT, further comparisons were 
carried out at AHVLA, taking ELISAs into account that were not available in 2012. Five 
ELISA tests from three manufacturers were compared to the PRNT published before.  
In the first table (Table 10), dams that had given birth to malformed lambs that were tested 
positive for Schmallenberg were analysed. It can therefore be assumed that the PRNT results 
reflect the reference, albeit at fairly low Ab titres at the time of analysis. While some ELISAs 
clearly struggle to detect the SBV antibodies, one test achieves a perfect match with the 
PRNT and two further ELISA provide acceptable results. 
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In the second part (Table 11), sheep infected in vivo with the FLI-SBV serum were analysed. 
After 4 weeks, all result between the PRNT and the ELISA “C” are matching again 
(important to note that sheep no 5 was resistant to the infection). Here also ELISA “E” is able 
to detect all samples correctly demonstrating the within 4 weeks after infection animals can 
securely be serologically detected by both validated VNT and ELISA methods.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 11. Schmallenberg virus: efficacy of current serological tools 
 
The direct and competitive SBV ELISA (ID-VET, France) able to detect SBV antibodies in 
ruminants, but also in other species, has been evaluated by ANSES/FLI and CODA-SERVA. 
Many published studies confirm that these ELISA are useful for the SBV sero-diagnosis and 
disease-surveillance studies in domestic and wild ruminant species in Europe (in goats, sheep 
and cattle). 
samples S/P % result S/P % result S/P % result S/P % result S/P % result titer result
220 58.3 negative 73.00 positive 30 positive 21.07 negative 66.70 positive 1/16 positive
227 61.3 doubtful 65.47 positive 19.5 positive 19.58 negative 45.28 doubtful 1/16 positive
231 48.6 negative 76.11 positive 14.4 positive 20.83 negative 62.63 positive 1/16 positive
233 57.4 negative 77.10 positive 17.15 positive 24.87 negative 56.84 positive 1/16 positive
247 28.9 negative 64.15 positive 24.6 positive 21.10 negative 58.95 positive 1/16 positive
657 43.5 negative 55.07 doubtful 31.02 positive 26.26 negative 69.96 positive 1/16 positive
232 37.7 negative 57.92 doubtful 25.49 positive 12.30 negative 36.51 negative 1/16 positive
PRNTEA B DC
samples S/P % result S/P % result titer result
Day 14
1 59.83 doubtful 66.38 positive
2 63.73 positive 89.20 positive
3 46.45 negative 58.35 positive
4 80.98 positive 63.85 positive
5 1.46 negative 1.99 negative
6 46.47 negative 44.48 doubtful
7 60.40 positive 65.07 positive
8 52.21 doubtful 43.60 doubtful
1 19.43 negative 16.05 negative
2 46.69 negative 42.83 doubtful
3 40.86 negative 32.97 negative
4 82.60 positive 69.46 positive
Day 21
1 76.11 positive 42.98 doubtful
2 75.41 positive 56.97 positive
3 76.10 positive 86.96 positive
4 62.77 positive 78.34 positive
5 0.95 negative 3.13 negative
6 52.03 doubtful 57.00 positive
7 53.93 doubtful 72.34 positive
8 38.48 negative 38.67 negative
1 22.22 negative 19.64 negative
2 55.05 doubtful 65.32 positive
3 62.27 positive 35.79 negative
4 35.11 negative 71.48 positive
Day 28
1 65.51 positive 23.65 positive 113.3 positive 1/64 positive
2 75.15 positive 15.76 positive 138.2 positive 1/32 positive
3 68.7 positive 14.38 positive 94.4 positive 1/64 positive
4 77.25 positive 10.99 positive 188.2 positive 1/128 positive
5 9.32 negative 83.45 negative 10.4 negative <4 negative
6 72.5 positive 11.97 positive 165 positive 1/128 positive
7 108.2 positive 14.9 positive 189.4 positive 1/64 positive
8 54.5 doubtful 18.99 positive 123.6 positive 1/64 positive
1 33.7 negative 16.46 positive 68.2 positive 1/64 positive
2 79 positive 7.82 positive 134.9 positive 1/64 positive
3 40.7 negative 19.16 positive 57.7 positive 1/64 positive
4 58.3 doubtful 22.9 positive 133.7 positive 1/64 positive
B C E PRNT
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3.2 Harmonisation and validation of RT-PCR tests 
 
3.2.1 Validation of diagnostic methods for Schmallenberg virus in bovine semen and 
field study in Germany 
 
Spiking experiments: Validation of extraction methods 
Twelve different manual and automatized extraction procedures were comparatively validated 
using dilution series of spiked semen, blood samples and minimum essential medium (MEM) 
as control (Table 12). In a second experiment, 8 SBV-RNA-positive semen batches (Cq 22.9-
37.4) collected from 5 bulls in the German field study (see below) were used for the 
assessment of performance characteristics of 5 of 12 methods (see Table 12) and one 
additional method – using Trizol® LS Reagent only (method 13). 
 
The highest diagnostic and analytical sensitivity for the extraction of SBV-RNA in semen was 
found for the Trizol® LS Reagent lysis (method 13) or in combination with a subsequent 
purification of the viral RNA based on magnetic beads using the MagAttract® Virus Mini 
M48 Kit at a KingFisher® Flex workstation (method 3). In contrast, the Chelex® 100 kit was 
proven to be the most unsuitable extraction procedure in this study (see Table 12 and Figures 
17 ab and 18). The diagnostic specificity of all tests was 100%.  
 
German field study 
Using the significantly most suitable extraction method (#3), frozen semen collected between 
May 2012 and November 2012 from 95 seroconverted bulls was analysed for SBV-RNA with 
real-time RT-PCR (RT-qPCR).  
 
A total of 766 semen batches from 95 SBV-infected bulls (56 fresh semen batches from 56 
bulls, and 710 straw batches from 94 bulls; from some collection days fresh semen as well as 
straws were available) were obtained from 7 stock-bull breeding centres in Germany in 2012. 
A total of 29 (3.8% of 766) semen batches from 11 bulls from 3 breeding centres were 
positive in RT-qPCR analysis with mean and median Cq-values of 33 ranging from 26 to 37. 
In 4 of the 11 bulls, SBV-genome positive semen was co-incidentally detected with first SBV-
antibodies. Multiple SBV-genome positive results were observed in 6 of the 11 bulls for a 
period of 3 days to 8 weeks in 2 to 11 consecutively collected semen batches (Fig. 19). In two 
of the bulls intermittent virus excretion could be observed within 3 and 8 weeks.  
 
Conclusions 
This study provides methods for the safe diagnosis of SBV-RNA in bovine semen. How long 
intermitting virus excretion may persist is currently unclear and will be the topic of further 
studies. This could have considerable consequences on the trade of semen from bulls in SBV-
affected regions. Similar to recommendations for BHV-1 testing in semen, we currently 
recommend to test two straws of each semen batch of SBV-infected (RNA or antibody 
positive) bulls in replicates for SBV-RNA to allow a reliable evaluation. 
Since the mere presence of RNA does not necessarily imply venereal transmission, 
subsequent in vivo and in vitro studies of the infectivity of SBV-RNA-positive semen were 
conducted, which were described in the previous section (Hoffmann et al. 2013). 
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Table 12. Extraction methods comparatively analysed for diagnostic and analytical sensitivity to detect SBV-
RNA in bull semen. Methods 1 to 12 were validated with SBV-spiked samples. Methods 1, 3, 4, 6, 7 and 13 (*) 
were assessed with SBV-RNA-positive semen samples from the field. Various statistical analyses revealed the 
highest sensitivity for methods 3 and 13 (Hoffmann et al. 2013).  
 
Method #  Pre-treatment (lysis) Extraction kit Extraction method Sample 
volume (µl) 
Diagnostic 
sensitivity (%) 
*1  ND MagAttract
b
  KingFisher Flex
h
 100 9.4 
2  Trizol
a
 MagAttract
b
  KingFisher Flex
h
 250 ND 
*3  Trizol
a
 MagAttract
b
 without 
lysis buffer 
KingFisher Flex
h
 250 96.9 
*4  ND RNeasy
c
 manual 200 50.0 
5  Trizol
a
 RNeasy
c
 manual 100 ND 
*6  Trizol
a
 RNeasy
c
 manual 250 71.9 
*7  ND QIAamp Viral RNA 
Mini
d
 
manual 75 46.9 
8  Addition of 75 µl of 
1-fold PBS to 
sample 
QIAamp Viral RNA 
Mini
d
 
manual 75 ND 
9  ND Total NA
e
 MagNa Pure
i
 100 ND 
10  ND QIAamp cador Pathogen 
Mini
f
 
manual 200 ND 
11  ND Chelex
g
 manual 10 ND 
12  ND Chelex
g
, supernatant 
extracted with RNeasy
c 
manual 10 ND 
*13  ND Trizol
a
 manual 250 96.9 
ND, not done; PBS, phosphate buffered saline; 
a
 Trizol® LS Reagent, Life Technologies, Darmstadt, Germany; 
b
 
MagAttract® Virus Mini M48 Kit, Qiagen, Hilden, Germany; 
c
 RNeasy® Mini Kit, Qiagen; 
d
 QIAamp® Viral 
RNA Mini Kit, Qiagen; 
e
 MagNA Pure® LC Total Nucleic Acid Isolation Kit, Roche Diagnostics, Mannheim, 
Germany; 
f
 QIAamp® cador® Pathogen Mini Kit, Qiagen; 
g
 Chelex® 100, Sigma-Aldrich, Steinheim, Germany: 
Protocol according to Wang et al. (2007); 
h
 KingFisher® Flex, Thermo Fisher Scientific, Schwerte, Germany; 
i
 
MagNA Pure® LC, Roche Diagnostics.  
 
 
 
Figure 17ab. RT-qPCR results of the two SBV-spiked and serially diluted matrices medium and semen 
extracted with 12 different methods in the spiking experiment (see also Table 1). Given Cq-values show means 
of replicates. Method 3 revealed the highest diagnostic and analytical sensitivity compared to the other methods. 
PCR results obtained with the matrixes serum (data not shown) and medium were very similar (Hoffmann et al. 
2013). 
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Figure18. Comparison of 6 extraction methods with SBV-RNA-positive semen samples obtained in the field 
study. Mean Cq-values by method ranged from Cq 33.7 to 44.2. Error bars show 95% confidence interval (CI). 
Methods 3 and 13 showed a significantly higher number and lower Cq-values compared to the other methods 
(Hoffmann et al. 2013).. 
 
 
 
 
Figure 19. Progression of Cq-values in semen samples of SBV-infected bulls collected between August and 
October  2012 in Germany and extracted with method 3 as measured by RT-qPCR. Two (F and H) of the six 
bulls with consecutive SBV-RNA positive semen batches showed intermittent virus excretion (Hoffmann et al. 
2013). 
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3.2.2 RT-PCR methods ring trials with different matrices to assess performance 
characteristics. 
 
The proficiency of methods for SBV-RNA extraction and detection used in 27 German and 17 
European laboratories was evaluated in two method trials. Four of the five European 
laboratories participated in both of the trials. A set of defined samples was provided by the 
Friedrich-Loeffler-Institut (FLI), Insel Riems. The specimens included serum, EDTA-treated 
whole-blood, tissue homogenates, RNA-eluates and bovine semen positive or negative for 
SBV-RNA. To determine the reference Cq-values at the FLI, serum, whole-blood and tissue 
homogenates were extracted with QIAamp® Viral RNA Mini kit (Qiagen), and semen 
samples with the significantly most efficient extraction method described previously 
(Hoffmann et al., 2013). Briefly, viral RNA in semen was lysed with Trizol® LS Reagent 
(Invitrogen) and subsequently purified using the MagAttract® Virus Mini M48 kit (Qiagen), 
which is based on magnetic beads, at a KingFisher® Flex workstation (Thermo Fisher 
Scientific). SBV-RNA was quantified using small-segment specific real-time RT-PCR (Bilk 
et al., 2012). All participants received straws of additional semen batches and the 
corresponding reference Cq-values to allow a validation of the recommended and the in-house 
RNA extraction methods conducted at their laboratories before the analysis of the specimens 
of the method trial. Detailed information on the SBV-RNA extraction and PCR-assays used 
by the different laboratories were recorded. The proficiency of different methods were 
comparatively analysed with respect to the PCR-results.  
The total number of specimens by matrix, their corresponding reference Cq-values and the 
extraction methods and PCR-protocols recommended by the FLI are given in tables 2 and 3. 
In the first (S1, B4, P2) and second (R7, T5, P1) method trial 6 specimens contained SBV-
RNA loads at the detection limit (≥Cq 35). For these specimens, positive and doubtful results 
were considered correct and will be referred to as ‘positive’. 
 
Results: 
For the matrices serum, whole-blood, tissue homogenate and RNA-eluate, results were 
provided by all participants of the first (n=43) and second (n=5) method trial, respectively.  
The method trial demonstrated that all extraction and PCR-procedures (100%) were robust to 
determine Cq-values of SBV-RNA below the detection limit in the matrices serum, whole-
blood, tissue homogenate and RNA-eluates generally similar to the reference Cq-values 
determined by the FLI. A high proportion of laboratories also detected borderline specimens, 
while the proportion of SBV-RNA-negative samples erroneously determined as positive and 
doubtful was low (8 of 189 results determined by 4 of 44 laboratories).  
Semen samples were tested for SBV-RNA by 18 of 27 national, 16 of 17 European (including 
the 5 SBV-Consortium laboratories). This study confirmed that the recommended methods 
have a high diagnostic sensitivity independent from the laboratory (92.7% for all semen 
samples; 100% for semen batches with Cq-values ≤35). Significant differences (p < 0.05) 
were found between means of the Cq-values of all three (P1-P3) semen batches tested in the 
first method trial and the single semen batches P1 and P2, respectively, when analysed by the 
recommended compared with other extraction procedures. A similar high proportion of 
positive results were obtained by the combination of Trizol® LS with any other (94.2%) than 
the MagAttract® Virus Mini M48 kit. In contrast, the use of other Trizol preparations with 
and without (72.7%)/or (50.0%) other kits revealed a considerably lower proportion of true 
positive results.  
The highest proportion of false negative results was found for the semen batch (n=7 of 10) 
with the highest Cq-value (Cq 36.4), which was comparatively analysed in the second method 
trial. This batch was also tested negative for SBV-RNA by two laboratories that used the 
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recommended extraction methods. Accordingly, it is important to thoroughly validate 
extraction methods with standardised reference semen batches to establish alternative 
extraction and PCR-protocols for a reliable diagnosis of SBV-RNA in bovine semen. The two 
semen batches negative for SBV-RNA (P5 and P7) were diagnosed as SBV-RNA-negative by 
all 5 laboratories in the second method trial.  
 
 
Table. Matrices and Cq-values of samples used for comparative SBV-RNA-testing in 27 national and 16 
European laboratories as measured by SBV-S3 RT-qPCR (Bilk et al., 2012) and recommendations given for 
extraction and PCR-assays by the Friedrich-Loeffler-Institut. 
 
  EDTA-blood 
(B) 
serum (S) tissue (T) 
homogenate 
semen (P) 
number of samples 5 5 5 3 batches 
Cq-value of positive 
samples 
22-38,  
no Cq  
27–37, 
no Cq 
15–26,  
no Cq 
30–35 
recommended 
extraction 
in-house RNA extraction Trizol® LS with/ without puri-
fication with magnetic beads* 
recommended PCR 
testing 
in-house PCR-protocol 
specifications report one result 
* MagAttract® Virus Mini M48 kit used at a used at a magnetic-bead separator. 
 
 
Table. Matrices and Cq-values of samples used for comparative SBV-RNA-testing in 5 European laboratories of 
the SBV-Consortium as measured by SBV-S3 RT-qPCR (Bilk et al., 2012). 
 
  RNA (R) serum (S) tissue (T) 
homogenate 
semen (P) 
number of samples 16 16 12 6 batches 
Cq-value of positive 
samples 
19–36,  
no Cq  
23–32,  
no Cq 
18–35,  
no Cq 
29–36,  
no Cq 
recommended 
extraction 
None QIAamp viral RNA mini kit 
and in-house RNA extraction 
Trizol® LS with/ without puri-
fication with magnetic beads* and 
in-house RNA extraction 
recommended PCR 
testing 
SBV-S3-RT-qPCR and in-house RT-qPCR 
specifications technical duplicates 2 biological and 2 technical 
replicates 
* MagAttract® Virus Mini M48 kit used at an automated or manual magnetic-bead separator. 
 
 
The methods used for SBV-RNA diagnosis in all matrices, except semen, were found robust 
to produce positive results for all clearly SBV-RNA-positive specimens and in a high number 
of samples with SBV-RNA loads at the detection limit.  
In contrast, the application of a suitable extraction method was found critical for a reliable 
diagnosis of SBV-RNA in bovine semen. The high sensitivity of the recommended, published 
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extraction methods for SBV-RNA diagnosis in bovine semen were confirmed by the method 
trial. Although several other extraction procedures in combination with Trizol® LS were 
found suitable, alternative methods should be thoroughly validated with standardised 
reference semen batches. Highly sensitive methods that allow the detection of Cq-values 
below the detection limit of Cq 35 are strongly recommended since infectivity of SBV-RNA-
positive semen with Cq-values around the detection limit cannot be excluded. SBV-RNA-
positive semen with a Cq-value of 34.2 has been infectious for subcutaneously injected cattle 
(Schulz et al., 2014).  
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4 Conclusions 
 
Schmallenberg virus primarily infects domestic and wild ruminants. Cattle and sheep seem to 
be the most susceptible species. Goats, pigs and camelids seem to be less susceptible. In 
pregnant cattle and sheep, the virus can infect multiple organs of the un-borne fetus. However, 
this infection often does not cause major lesions and infrequently leads to malformations. 
Serological evidence of a previous SBV-infection were found in various wild ruminant 
species and dogs. Seroprevalence varied among different species. No SBV-infection was 
found in horses, poultry and in wild mice. Schmallenberg virus did infect 
immunocompromised (IFNAR -/-) mice.  
Certain species of Palearctic Culicoides biting midges are the main vectors of SBV. 
Transovarial SBV-transmission in culicoids has not been observed.  
Schmallenberg virus was introduced in Europe in 2011. After exposure SBV rapidly spread 
within naive herds, and also throughout winter. Blood samples collected before the first 
clinical cases of SBV were observed in Europe in 2011, were all tested negative for SBV 
antibodies. The origin of the virus remains unknown.  
Schmallenberg virus was detected in semen and embryos from SBV-infected cattle and sheep, 
respectively. By the end of 2012, a frequency of 0-4% SBV-RNA-positive bovine semen 
batches was found in the participating countries. Subcutaneous injection of SBV-RNA-
positive semen in cattle demonstrated that semen from SBV-infected cattle may contain 
viable SBV. In vitro studies with embryos suggest a negligible risk for SBV-transmission. 
Whether infectious virus can be transmitted to susceptible cows at service or by insemination, 
still needs to be elucidated. Since the role of SBV-contaminated gametes in the epidemiology 
of SBV is still unknown, additional studies are required.  
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5 Recommendations 
 
Schmallenberg virus has rapidly spread over Europe reaching prevalences in cattle and sheep 
of close to 100%.  Two years after the virus was first detected, the outbreak seems to be over 
in the countries first affected. However, since the number of susceptible animals in Europe is 
rising since 2013, we need to be aware of potential recurrent cases in EU countries and a basic 
SBV surveillance is recommended.  
 
The role of SBV-contaminated semen in the epidemiology of SBV is still unknown. Therefore 
additional studies on SBV transmission via artificial insemination are required.  
 
Since it remains unknown how Schmallenberg virus was introduced in Europe the tracing 
back of the SBV origin and in relation to that studies on strain variation of SBV and other 
Simbu serogroup viruses is indicated. A risk analysis of possible ways of introduction should 
be considered, this may be helpful to avoid new introduction of such viruses in future. 
 
To early detect new emerging (arthropod-borne) viruses, monitoring of sentinel herds in 
European countries together with midge trapping on the same farms to study vector 
epidemiology would be useful. In parallel methods to detect new and emerging diseases in 
livestock need to be established and/or maintained across Europe.  
 
The culiciodes vector seems to play a more and more important role in the transmission of 
Orthobunyaviruses in Europe. To better understand this and also to find out how this is 
influenced by climate change vector competences of Schmallenberg virus and related Simbu 
serogroup orthobunyaviruses need further study. 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
62  
 
6 Scientific Publications of the studies  
 
Bréard E, Lara E, Comtet L, Viarouge C, Doceul V, Desprat A, Vitour D, Pozzi N, Cay AB, 
De Regge N, Pourquier P, Schirrmeier H, Hoffmann B, Beer M, Sailleau C, Zientara S. 
Validation of a commercially available indirect ELISA using a nucleocapside 
recombinant protein for detection of schmallenberg virus antibodies. PLoS One. 
2013;8(1):e53446. doi: 10.1371/journal.pone.0053446. Epub 2013 Jan 15. 
 
Beer M, Conraths FJ, van der Poel WHM. 2013. 'Schmallenberg virus'--a novel 
orthobunyavirus emerging in Europe. Epidemiol Infect. Jan;141(1):1-8. doi: 
10.1017/S0950268812002245. Epub 2012 Oct 10. 
 
Chaintoutis SC, Kiossis E, Giandinis ND, Brozos CN, Sailleau C, Viarouge C, Bréard E, 
Papanastassopoulou M, Zientara S, Papadopoulos O, Dovas CI. 2013. Evidence of 
Schmallenberg virus circulation in ruminants in Greece. Trop Anim Health Prod (IF 
2012 : 1,09). 2013 Jul 19. [Epub ahead of print]. 
 
Conraths FJ, Peters M, Beer M. 2013. Schmallenberg virus, a novel orthobunyavirus infection 
in ruminants in Europe: Potential global impact and preventive measures. New Zealand 
Vet. J. 61, 63-67. 
 
Conraths FJ, Kamer D, Teske K, Hoffmann B, Mettenleiter TC, Beer M. 2013. Reemerging 
Schmallenberg Virus Infections, Germany, 2012. Emerg. Infect. Dis. 
http://dx.doi.org/10.3201/eid1903.121324. 
 
De Regge N, De blauwe I, De Deken R, Vantieghem P, Madder M, Geysen D, Smeets F, 
Losson B, van den Berg T, Cay AB Detection of Schmallenberg virus in different 
Culicoides spp. by real-time RT-PCR. Transbound Emerg Dis. 2012 Dec;59(6):471-5. 
doi: 10.1111/tbed.12000. Epub 2012 Oct 1. 
 
De Regge N, Madder M, Deblauwe I, Fassotte C., Losson B, Demeulemeester J, Tomme M, 
Smeets F, Cay B. Schmallenberg virus circulation in Culicoides in Belgium in 2012: 
Field validation of a real time RT-PCR approach to assess virus replication and 
dissemination in midges. Plos One, 2014. e87005. 
 
De Regge N, van den Berg T, Georges L, Cay B. Diagnosis of Schmallenberg virus infection 
in malformed lambs and calves and first indications for virus clearance in the fetus.Vet 
Microbiol. 2013 Mar 23;162(2-4):595-600. 
 
Doceul V, Lara E, Sailleau C, Belbis G, Richardson J, Bréard E, Viarouge C, Dominguez M, 
Hendrikx P, Calavas D, Desprat A, Languille J, Comtet L, Pourquier P, Elouet JF, 
Delmas B, Marianneau P, Vitour D, Zientara S. 2013. Epidemiology, molecular 
virology and diagnostics of Schmallenberg virus. Vet Research, (IF 2011 : 4,06), May 
15;44(1):31. doi: 10.1186/1297-9716-44-31. 
 
Elbers AR, Meiswinkel R, van Weezep E, van Oldruitenborgh-Oosterbaan MM, Kooi EA. 
Schmallenberg virus in Culicoides spp. biting midges, the Netherlands, 2011. Emerg 
Infect Dis. 2013 Jan;19(1):106-9. doi: 10.3201/eid1901.121054. 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
63  
 
Elbers ARW, Meiswinkel R, van Weezep E, Kooi EA, van der Poel WHM. Schmallenberg 
virus in Culicoides biting Midges in the Netherlands in 2012. Transbound. Emerg. Dis. 
(in press); doi:10.1111/tbed.12128. 
 
Fischer M, Schirrmeier H, Wernike K, Wegelt A, Beer M, Hoffmann B. Development of a 
pan-Simbu real-time reverse transcriptase PCR for the detection of Simbu serogroup 
viruses and comparison with SBV diagnostic PCR systems. Virol J. 2013 Nov 
5;10(1):327. [Epub ahead of print]. 
 
Fischer M, Hoffmann B, Goller KV, Höper D, Wernike K, Beer M (2013). A mutation ‚hot 
spot‘ in the Schmallenberg virus M segment. J. Gen. Virol. 94: 1161-1167 
 
Goller KV, Höper D, Schirrmeier H, Mettenleiter TH, Beer M (2012). Schmallenberg virus as 
possible ancestor of Shamonda virus. Emerg. Infect. Dis. 18(10) 
http://dx.doi.org/10.3201/eid1810.120835 
 
Hoffmann B., Scheuch M, Höper D, Jungblut R, Holsteg M, Schirrmeier H, Eschbaumer M, 
Goller KV, Wernike K, Fischer M, Breithaupt A, Mettenleiter TC, Beer M (2012). 
Novel orthobunyavirus in cattle, Europe, 2011. Emerg Infect Dis 18, 469–472. 
 
Hoffmann B, Schulz C, Beer M. First detection of Schmallenberg virus RNA in bovine 
semen, Germany, 2012. Vet Microbiol. 2013 Dec 27;167(3-4):289-95. doi: 
10.1016/j.vetmic.2013.09.002. Epub 2013 Sep 12. 
 
Hulst M, Kortekaas J, Hakze-van der Honing R, Vastenhouw S, Cornellissen J, van Maanen 
K, Bossers A, Harders F, Stockhofe N, van der Poel WHM. Genetic characterization of 
an atypical Schmallenberg virus isolated from the brain of a malformed lamb. Virus 
Genes. 2013 Dec;47(3):505-14. doi: 10.1007/s11262-013-0975-2. Epub 2013 Aug 31. 
 
Mansfield KL, Rocca SA, Khatri M, Johnson N, Steinbach F, Fooks AR. Detection of 
Schmallenberg virus serum neutralising antibodies. J Virol Methods. 2013 Mar;188(1-
2):139-44. doi: 10.1016/j.jviromet.2012.11.031. Epub 2012 Nov 29. Review. 
 
Méroc E, Poskin A, Van Loo H, Van Driessche E, Czaplicki G, Quinet C, Riocreux F, De 
Regge N, Caij B, van den Berg T, Hooyberghs J, Van der Stede Y. Follow-up of the 
Schmallenberg Virus Seroprevalence in Belgian Cattle. Transboundary and emerging 
diseases. 2014. Ahead of print. Doi: 10.1111/tbed.12202 
 
Méroc E, Poskin A, Van Loo H, Quinet C, Van Driessche E, Delooz L, Behaeghel I, Riocreux 
F, Hooyberghs J, De Regge N, Caij AB, van den Berg T, van der Stede Y. Large-scale 
cross-sectional serological survey of schmallenberg virus in belgian cattle at the end of 
the first vector season. Transbound Emerg Dis. 2013 Feb;60(1):4-8. 
 
Laloy E, Bréard E, Sailleau C, Viarouge C, Desprat A, Zientara S, Klien F, Hars J, Rossi S. 
2013. Serological survey of Schmallenberg virus in red deer (Cervus elaphus), France, 
2010- 2012. Emerg. Infect. Dis. (IF 2012 : 5,993), accepted. 
 
Ponsart C, Pozzi N, Catinot V, Viard G, Viarouge C, Bréard E, Zientara S, Virtour D. 2013. 
First evidence of excretion of the Schmallenberg virus in bull semen. Vet Research (IF 
2012 : 4,06), accepted. 
Technical and scientific studies on  Schmallenberg virus 2014 
 
64  
 
 
Poskin A, Van Campe W, Mostin L, Cay B, De Regge N. Experimental Schmallenberg virus 
infection of pigs. Veterinary microbiology, 2014, in press. 
 
Rosseel T, Scheuch M, Höper D, De Regge N, Caij AB, Vandenbussche F, Van Borm S. 
DNase SISPA-next generation sequencing confirms Schmallenberg virus in Belgian 
field samples and identifies genetic variation in Europe. PLoS One. 2012;7(7):e41967. 
 
Salleau C, Bréard E, Viarouge C, Desprat A, Doceul V, Lara E, Langguille J, Virtour D, 
Attoui H, Zientara S. 2013.Acute Schmallenberg Virus Infections, France, 2012. 
Emerging Infect. Diseases (IF 2011 : 6,17), vol 19, n°2, (2):321-322. 
 
Sailleau C, Boogaerts C, Meyrueix A, Laloy E, Bréard E, Viarouge C, Desprat A, Vitour D, 
Doceul V, Boucher C, Zientara S, Grandjean D. 2013. Schmallenberg virus infection in 
Dogs, France, 2012. Emerg. Infect. Dis (IF 2012 : 5,993), Vol 19(11), n°11, doi: 
10.3201/eid1911.130464. 
 
Scholte EJ, Mars MH, Braks M, DEN Hartog W, Ibañez-Justicia A, Koopmans M, Koenraadt 
CJ, DE Vries A, Reusken C (2014). No evidence for the persistence of Schmallenberg 
virus in overwintering mosquitoes. Med Vet Entomol 28, 110-115. 
 
Schulz, C., Wernike, K., Beer, M., Hoffmann, B., 2014. Infectious Schmallenberg virus from 
bovine semen, Germany. Emerging infectious diseases 20, 
http://dx.doi.org/10.3201/eid2002.131436. 
 
Van der Heijden HM, Bouwstra RJ, Mars MH, van der Poel WH, Wellenberg GJ, van 
Maanen C. Development and validation of an indirect Enzyme-linked Immunosorbent 
Assay for the detection of antibodies against Schmallenberg virus in blood samples 
from ruminants. Res Vet Sci. 2013 Oct;95(2):731-5. doi: 10.1016/j.rvsc.2013.04.022. 
Epub 2013 May 16. 
 
Van der Poel WHM, Parlevliet JM, Verstraten ER, Kooi EA, Hakze-Van der Honing R, 
Stockhofe N. Schmallenberg virus detection in bovine semen after experimental 
infection of bulls. Epidemiol Infect. 2013 Oct 9:1-6. [Epub ahead of print]. 
 
Van der Poel WHM, Cay B, Zientara S, Steinbach F, Valarcher JF, Bøtner A, Mars MH, 
Hakze-van der Honing R, Schirrmeier H, Beer M. 2014. Limited interlaboratory 
comparison of Schmallenberg virus antibody detection in serum samples. Vet Rec 
March 3, 2014. 
 
Wernike K, Hoffmann B, Bréard E, Botner A, Ponsart C, Zientara S, Lohse L, Pozzi n, 
Viarouge C, Sarradin P, Leroux-Barc C, Riou M, Breithaupt A, Beer M. 2013 
Schmallenberg virus experimental infection of sheep. Vet Microbiol (IF 2012 : 3,252, 
pii: S0378-1135(13)00345-3. 
 
Wernike K, Silaghi C, Nieder M, Pfeffer M, Beer M. Dynamics of Schmallenberg virus 
infection within a cattle herd in Germany, 2011. Epidemiol Infect. 2013 Oct 16:1-4. 
 
Wernike K, Eschbaumer M, Schirrmeier H, Blohm U, Breithaupt A, Hoffmann B, Beer M. 
Oral exposure, reinfection and cellular immunity to Schmallenberg virus in cattle. Vet 
Technical and scientific studies on  Schmallenberg virus 2014 
 
65  
 
Microbiol. 2013 Jul 26;165(1-2):155-9. http://dx.doi.org/10.1016/j.vetmic.2013.01.040. 
Epub 2013 Feb 7. 
 
Wernike, K., Kohn, M., Conraths, F.J., Werner, D., Kameke, D., Hechinger, S., Kampen, H., 
Beer, M., 2013c. Transmission of Schmallenberg virus during winter, Germany. Emerging 
infectious diseases 19. http://dx.doi.org/10.3201/eid1910.130622 
 
Zanell G, Raballand C, Durand B, Sailleau C, Peltzer S, Durand F, Zientara S, Breard E. 
2013. Likely introduction date of Schmallenberg virus in France according to monthly 
serological surveys in cattle. Transboundary and Emerging Dis. (IF 2013 ; 2,096), 
accepted. 
 
 
 
 
 
 
 
Technical and scientific studies on  Schmallenberg virus 2014 
 
66  
 
7 Contributors of the studies 
 
Friedrich-Loeffler-Institut (FLI),  Südufer 10, 17493 Greifswald-Insel Riems, Germany:  
Dr Patricia König, 
Dr. Kerstin Wernike, 
Kerstin Tauscher, 
Dr. Angele Breithaupt, 
Dr Claudia Schulz,  
Dr Bernd Hoffmann, 
Dr Martin Beer 
Friederike Querengässer, 
Dr. Detlef Höreth-Böntgen, 
Dr Helge Kampen, 
Daniela Kameke, 
Prof. Dr. Franz J. Conraths, 
Dr Susan Mouchantat 
Horst Schirrmeier 
 
Central Veterinary Institute of Wageningen University and Research Centre (CVI), 
Edelhertweg 15, 8219 PH  Lelystad, The Netherlands: 
Dr. Armin Elbers, 
Dr. Bart Kooi, 
Dr. Norbert Stockhofe 
Dr. Sander Koenraadt (WUR) 
Renate Hakze van der Honing 
Betty Verstraten 
Prof. Dr. Wim H. M. van der Poel 
 
Animal Health and Veterinary Laboratories Agency (AHVLA), United Kingdom; 
Ms Sudha Arumagam   
Dr Ashley Banyard  
Dr. Akbar Dastjerdi  
Prof. Dr. Anthony Fooks 
Dr Derek Healey  
Dr. S. Anna La Rocca 
Ms. Meenakshi Khatri 
Ms. Siva Karuna 
Dr. Karen Mansfield 
Ms. Julie Peake  
Prof. Dr. Falko Steinbach 
 
Veterinary and Agrochemical Research Centre (VAR-CODA-CERVA), Belgium; 
Dr. Nick de Regge 
Dr. Brigitte Cay 
Dr. Thierry van den Bergh 
Dr. Antoine Poskin 
 
L'Agence nationale chargée de la sécurité sanitaire de l'alimentation, de l'environnement et du 
travail (ANSES), France; 
Dr. Stephan Zientara (ANSES), 
Technical and scientific studies on  Schmallenberg virus 2014 
 
67  
 
Dr. Claire Ponsart (LNCR) 
Dr. Emmanuel Breard  
Dr. Eva Laloy  
 
Institut national de la recherche agronomique (INRA), France; 
Dr. Thierry Pineau 
Dr. Sascha Trapp 
Dr. Pierre Sarradin 
Dr. Mickael Riou 
Céline Barc 
 
Laboratoire national de contrôle des reproducteurs (LNCR), France; 
Dr. Claire Ponsart 
Nathalie Pozzi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
